How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski

Dr. Scott Kanoski, PhD, is a Professor of Human and Evolutionary Biology and Neurobiology at the University of Southern California. We discuss how different foods impact memory and cognitive function as well as cravings. We also discuss how GLP-1 drugs work to control hunger in the brain and body, the role of the gut microbiome, and the effects of artificial and low calorie sweeteners on hunger and satiety. This episode highlights how nutrition impacts much brain health and learning capacity and how our memory impacts food choices too. Read the full episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Function: https://functionhealth.com/huberman Helix Sleep: https://helixsleep.com/huberman LMNT: https://drinklmnt.com/huberman Our Place: https://fromourplace.com/huberman Timestamps (00:00:00) Scott Kanoski (00:02:33) GLP-1, Natural GLP-1 Production; GLP-1 Drugs, Microdosing (00:07:06) GLP-1 Drugs & Benefits (00:10:36) Sponsor: Our Place & Helix Sleep (00:13:24) GLP-1 & Hunger Suppression, Vagus Nerve; Food Noise (00:18:39) Artificial Sweeteners & Appetite, Preclinical Studies (00:26:50) Memory & Meals; Stress; Eating & Individualization, Fasting (00:33:42) Memory Impairments, Western Diet, High Sugar, Processed Food (00:42:33) Sponsor: AG1 (00:43:46) Dementia, Alzheimer’s Disease & Western Diet; Exercise (00:49:40) Vagus Nerve, Hippocampus & Memory, Hormones (00:57:10) Sugar & Fat Consumption, Memory; Engineering Food for Quality (01:04:32) GLP-1s, Nutrient Deficiency, Weight Loss & Other Effects (01:11:33) Sponsor: LMNT (01:12:54) Vagus Nerve & Hippocampus, Eating & Acetylcholine (01:21:05) Hippocampus, Memory & Food; Interoceptive Awareness & Western Diet (01:27:21) Omega-3s; Microbiome & Processed Foods (01:34:00) Microbiome, Antibiotics, C. diff Infection (01:37:23) Sponsor: Function (01:39:01) Foods to Enhance Microbiome; Rising Obesity & Highly Processed Food (01:43:39) Dopamine & Food Choice, Change Food Cravings (01:49:50) Food Addiction, Highly Processed Foods; Political Lobbying (01:56:43) Oxytocin, Reduced Food Consumption, Social Eating (02:00:11) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Social Media, Neural Network Newsletter Learn more about your ad choices. Visit megaphone.fm/adchoices

Speaker names marked ? are inferred from speaking time and the show’s known hosts — they are not voice-verified.

• 0:00Speaker 00

  When I started studying how diet impacts neurocognition and memory function, the first model we were studying was a high-sugar model. The animals basically had ad libitum access to a sugar solution, about the same percentage of calories as a soft drink that we consume, and otherwise they had healthy food and water. And with this model, the animals show hippocampal-dependent memory deficits when they're older, and these seem to persist later into life, even though they're not consuming the sugar anymore. There may be a role for the microbiome, there's some changes in the bacteria in the gut from the sugar model that that may have a functional connection to the memory impairments. We've also looked at models where the animals are consuming like a total junk food diet.

• 0:44Speaker 00

  So we give them chocolate peanut butter cups, ruffled potato chips, rodent, high-fat, high-sugar diet. They show these memory impairments that last even after you switch them to a healthy diet.

• 0:56Andrew D. Huberman?

  Welcome to the Huberman Lab Podcast, where we discuss science and science-based tools for everyday life.

• 1:05Andrew D. Huberman?

  I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. My guest today is Dr. Scott Kanoski. Dr. Scott Kanoski is a professor of human and evolutionary biology and neurobiology at the University of Southern California. His lab studies how hunger and memory interact, and how the mind and body impact appetite, body weight regulation, food craving, and choice. Dr. Kanoski's lab also studies how different types of nutrients impact brain development and brain function later in life. Today, we discuss many topics, including GLP drugs, how they work, how they impact hunger, and how they impact things like longevity, cognition, and drives in general.

• 1:47Andrew D. Huberman?

  As you'll soon see, Dr. Scott Kanoski is an encyclopedia of useful information about how your brain and body control your relationship to food. And today, he shares that knowledge with you in a clear, unbiased, and in many cases, actionable way. It's a conversation about the interactions that occur between your brain and body involving hormones, neurotransmitters, your memory, and your experiences that I'm confident will powerfully inform how you think about food, your food choices, and nutrition in general. Before we begin, I'd like to emphasize that this podcast is separate from my teaching and research roles at Stanford. It is, however, part of my desire and effort to bring zero cost to consumer information about science and science-related tools to the general public. In keeping with that theme, today's episode does include sponsors.

• 2:30Andrew D. Huberman?

  And now for my conversation with Dr. Scott Kanoski. Dr. Scott Kanoski, welcome.

• 2:36Speaker 00

  Thank you. Pleasure to be here. Thanks for the invitation.

• 2:39Andrew D. Huberman?

  You work on a topic that people experience every day, which is hunger, feeding, and hopefully satiety. But we also have this obesity epidemic, which seems to be partially mitigated by the GLP drugs. But there's a lot to this whole thing that we call hunger in food and appetite and weight and all of that. And today, you'll educate us about all of it. But to start things off, because it's on everybody's mind, what are the GLPs? What is this glucagon-like peptide 1 in its natural form in the body? And then perhaps we can talk about the drugs that increase their levels, because either everyone's taking one of these now, coming off of one of these now, thinking about taking

• 3:22Andrew D. Huberman?

  one, hates the idea that anyone's taking them, or is, has someone that they know is taking one. So GLPs are here.

• 3:31Speaker 00

  In its natural form, it's an incretin hormone. So it's secreted from the distal intestines around food ingestion. So there's a little bit of secretion before the meal actually starts, then there's additional secretion during the meal, and this gets into circulation. There's also a source of GLP-1 that's produced in the brain, in the brainstem, nucleus tractus solitarius. There's a population of neurons that make GLP-1 and then extensively send GLP-1 message throughout the brain.

• 4:03Andrew D. Huberman?

  What do those do? Are they related to hunger as well?

• 4:05Speaker 00

  The peripheral GLP-1 and the central GLP-1 have very similar effects. So they're involved in hunger suppression, but they seem to be operating independently. So there doesn't seem to be a strong connection between the peripheral GLP-1 physiological system and the neurons that make GLP-1 in the brain. But they do both have appetite-suppressing effects.

• 4:25Andrew D. Huberman?

  But presumably, they're doing other things as well, right?

• 4:28Speaker 00

  Yeah, they're helping to regulate blood glucose levels, to stimulate insulin secretion when there's high levels of glucose present in the blood. In fact, the first application of GLP-1-based drugs was for diabetes treatment, not for obesity, but because they also suppress appetite and food intake, which leads to body weight loss. Now, they're probably more widely known for their weight loss capacity in the present day, but they started off as diabetes treatment.

• 4:57Andrew D. Huberman?

  My understanding is that the GLP-1 drugs, so Ozempic, Wegovy, and on and on, that they increase levels of GLP-1 thousandfold more than we ever experienced naturally.

• 5:10Speaker 00

  That's correct. Superphysiological, for sure.

• 5:12Andrew D. Huberman?

  Is there anything known about the potential downside to that or upside?

• 5:18Speaker 00

  Well, I mean, most of what we know is an upside. I mean, the people have been taking GLP-1-based drugs for over a decade now, and the clinical trials support the efficacy of these drugs. There are side effects, nausea and emesis, emesis being vomiting, the most common side effects. And this can lead to discontinuation in a lot of people. They kind of tolerate it for a certain period of time, and then at some point, discontinue the treatment. So if there's any primary limitation of these drugs, it's trying to mitigate those side effects and to have more long-term efficacy beyond the initial weight loss.

• 5:57Andrew D. Huberman?

  I hear that some people nowadays are taking far less than they are prescribed. So microdosing, a term borrowed, obviously, from the psychedelics community, in order to offset some of the side effects, still get some appetite suppression, and perhaps also reduce their cost, because some of these are quite expensive, although many are moving to generic forms. Are there any animal and/or human data that you're aware of on microdosing? Or is this just a natural experiment that people are doing?

• 6:23Speaker 00

  I'm not aware of any data on that.

• 6:28Speaker 00

  Placebos are very effective, so there could be some of that involved. I'm old-fashioned, and I like to see the large clinical trials, randomized controlled clinical trials, before I start to believe something's actually working. And we just don't have those studies to date on microdosing.

• 6:46Andrew D. Huberman?

  Seems like they probably won't be done. I mean, there's not really an incentive for the drug companies any way to do it. People taking less, buying less, seems like not a good business strategy.

• 6:55Speaker 00

  These studies are so expensive to conduct that it's unlikely that anyone's doing that right now, or that they won't in the near future. So we're kind of left with anecdotal reports in that zone.

• 7:06Andrew D. Huberman?

  I also hear about some non-weight loss-related benefits of the GLPs. In fact, I know people who are of healthy body weight, who are taking quote-unquote "microdoses," or even full doses, in order to glean what they claim are some of the benefits on cognition, on energy. A friend who is diagnosed with chronic fatigue syndrome has been microdosing it, and she loves the effects. She's working with a physician, obviously. She doesn't like the appetite suppression, because she's already very lean and not underweight, but close to it. But it speaks to the possibility that taking or elevating levels of GLP-1 could be beneficial for things unrelated to the weight loss.

• 7:47Speaker 00

  Absolutely. The receptor for GLP-1 is not exclusively expressed in regions of the brain that control appetite and food intake and glucose regulation. They're pretty densely expressed throughout the brain. And this is including regions that are in the reward circuitry in the brain, the mesostriatal pathway. There's receptors in the midbrain VTA, the striatum, nucleus accumbens. One of my favorite brain regions is the hippocampus, which has a lot of GLP-1 receptors. So there's definitely possibility of applications for these drugs, or different GLP-1 receptor agonists for substance abuse disorder, and potentially even memory disorders and dementia.

• 8:30Speaker 00

  And there's a lot of, certainly, preclinical data to support that. The clinical data are just ongoing and starting to come out now. And part of the idea with the applications of GLP-1 receptor agonists to things other than appetite suppression has to do with the capacity of these drugs to get into the brain. This is somewhat of a controversial topic in our field of research. The first generation of GLP-1 drugs, so 2005 to 2012, we collected some preclinical evidence in rodents suggesting that a large part of the mechanism of action for food intake suppression was through brain action. So the drugs would get into the brain, activate receptors.

• 9:15Speaker 00

  Whether these newer generations of GLP-1 drugs, like Ozempic, Wegovy, are getting into the brain is less clear.

• 9:22Andrew D. Huberman?

  Really?

• 9:22Speaker 00

  Again, controversial. So some studies will, mostly preclinical, exclusively preclinical, will tag the peptides with a fluorescent molecule and try to look at where it accumulates in the brain. And you see a lot of it clump into what's called the circumventricular organs, where there's no blood-brain barrier protecting the brain from the circulation. So there's a school of thought that these drugs are acting primarily in those circumventricular organs. But those studies are tricky, because fluorescent molecules fade, and the brain has autofluorescent signal. So we could be missing something with those fluorescent studies. There's better ways to do this, but it's expensive and complicated, where you radiolabel

• 10:07Speaker 00

  the peptides with like carbon 14, and you can actually determine if it's getting into the brain and where. Those studies, Elizabeth Ria, Bill Banks, and colleagues at University of Washington are starting to do some of those. And it looks like some of the early generation of GLP-1 drugs readily get into the brain, and some of the newer ones, less clear. Maybe it takes a little bit longer, but the jury's still out. Where they're getting into the brain is not something we have a clear understanding of at this point.

• 10:36Andrew D. Huberman?

  I'd like to take a quick break to acknowledge our sponsor, Our Place. Our Place makes my favorite pots, pans, and other cookware. Surprisingly, toxic compounds such as PFASs, or forever chemicals, are still found in 80% of nonstick pans, as well as utensils, appliances, and countless other kitchen products. As I've discussed before on this podcast, these PFASs, or forever chemicals like Teflon, have been linked to major health issues such as hormone disruption, gut microbiome disruption, fertility issues, and many other health problems. So it's very important to avoid them. This is why I'm a huge fan of Our Place. Our Place products are made with the highest quality of materials and are all PFAS and toxin-free. I particularly love their Titanium Always Pan Pro.

• 11:20Andrew D. Huberman?

  It's the first nonstick pan made with zero chemicals and zero coating. Instead, it uses pure titanium. I cook eggs in my Titanium Always Pan Pro almost every morning. The design allows for the eggs to cook perfectly without sticking to the pan. So if you're looking for non-toxic, long-lasting pots and pans, go to fromourplace.com/huberman and use the code HUBERMAN. With a 100-day risk-free trial, free shipping, and free returns, you can try Our Place with zero risk, and you can see why more than 1 million people have made the switch to Our Place kitchenware. Today's episode is also brought to us by Helix Sleep. Helix Sleep makes mattresses and pillows that are customized to your unique sleep needs. Now, I've spoken many times before on this and on other podcasts about the fact that

• 12:04Andrew D. Huberman?

  getting a great night's sleep is the foundation of mental health, physical health, and performance. When we aren't getting great sleep on a consistent basis, everything suffers. And when we are sleeping well and enough, our mental health, physical health, and performance in all endeavors improve markedly. Now, the mattress you sleep on makes a huge difference in the quality of sleep that you get each night. How soft it is, or how firm it is, all play into your comfort and need to be tailored to your unique sleep needs. If you go to the Helix website, you can take a brief two-minute quiz, and it will ask you questions such as, do you sleep on your back, your side, or your stomach? Maybe you know, maybe you don't. Do you tend to run hot or cold during the night? Things of that sort. You answer those questions, and Helix will match you to the ideal mattress for you.

• 12:46Andrew D. Huberman?

  For me, that turned out to be the DUSK mattress. I've been sleeping on a DUSK mattress for more than four years now, and it's been far and away the best sleep that I've ever had. If you'd like to try Helix, you can go to helixsleep.com/huberman, take that two-minute sleep quiz, and Helix will match you to a mattress that's customized for you. Right now, Helix is giving up to 27% off their entire site. Helix has also teamed up with TruMed, which allows you to use your HSA/FSA dollars to shop Helix's award-winning mattresses. Again, that's helixsleep.com/huberman to get up to 27% off. I'm sort of veering us toward reward and reinforcement and memory, because even

• 13:30Andrew D. Huberman?

  though those are topics that come up in the context of drug-seeking, of pleasure-seeking, and on and on, in the context of food, what we consider rewarding and what we crave are very closely related. And memory for what we think is going to soothe us is also, or satisfy us at the level of food, is also, seems to be a strong component. I know you've worked in these areas, but as a way of getting directly there, I'm very curious how the GLPs are actually suppressing hunger. Let's assume that it doesn't get into the brain, that these drugs aren't getting into the brain. So if I take a full dose or a microdose of a GLP-1 drug, what is the sensation that people report?

• 14:14Andrew D. Huberman?

  I've never actually taken one, so I don't know. Okay. But presumably, it's satiety, but does that mean fullness? People will talk about reducing "food noise," in air quotes. What is this at the level of biology?

• 14:29Speaker 00

  So the GLP-1, normal physiological GLP-1 that we secrete in the body likely has a paracrine mechanism of action.

• 14:38Andrew D. Huberman?

  Could you describe paracrine?

• 14:39Speaker 00

  Yeah, so the vagus nerve innervates our GI tract, and there's receptors for GLP-1 on the terminal. So right where the nerve is contacting the gastrointestinal tract, there's GLP-1 receptors. And this paracrine mechanism is where the GLP-1 is released from these L cells in the intestines and immediately act on nearby receptors that are expressed on the vagus nerve. So that's one mechanism through which GLP-1, both the GLP-1 drugs as well as our physiological GLP-1, may be producing this feeling of satiation. So the vagus nerve communicates a lot of within-meal signals that contribute to us stopping eating, right? At some point, we get full. This process is called satiation.

• 15:24Speaker 00

  GLP-1 is a big player in that process. Not exclusively through the vagus nerve, but probably largely through the vagus nerve, through this paracrine mode of action. So this sends a signal to the brain stem, that's the first site in the brain where the vagus nerve signals to, that the animals had enough food at this point. The stomach's starting to expand, there's nutrients entering the intestines, and there's sort of a symphony of signals that some act through the vagus nerve, some don't, but eventually lead to this feeling of fullness and meal termination. And GLP-1 is one instrument in that symphony.

• 16:03Andrew D. Huberman?

  Does it turn off the desire for food as well? Like, people will talk about less food noise. And I know many people who are taking these drugs, some of whom are really bullish about also exercising, some who aren't, so we'll get to that a little later. But they all talk about reduced food noise, which tells me that before, there was noise. And I don't know, because I haven't asked them whether they were aware of that noise. So I'm trying to imagine, having never taken one of these, what that noise is. I mean, when I see blueberries, I want to eat them. But when I see bread, or a steak, or something, I may or may not want to eat them, depending on when I ate last, time of day, this kind of thing. So what is food noise?

• 16:46Speaker 00

  I am not someone who experiences food noise either, so it's a bit of a strange idea to me. But I've certainly heard, same as you, anecdotal evidence of people who are taking GLP-1-based drugs and are saying that, wow, it really, really canceled the food noise. Whether that's based on receptor binding in the brain, in higher-order brain regions that are involved in memory and cognition, hippocampus prefrontal cortex, we don't know. Again, I think that's one of the big gaps in this field, is understanding where the drugs are acting. Are they getting to these regions in the brain that are involved in higher-order cognitive

• 17:28Speaker 00

  processes that may mediate the food noise? Or is this basically just a gut-vagus satiation mechanism? It's a lot to uncover in that area still.

• 17:41Andrew D. Huberman?

  What's the evidence that the vagus nerve is crucial for the action of GLPs in suppressing hunger?

• 17:47Speaker 00

  If you do a selective lesion to the sensory vagus nerve as it comes up from the GI tract to the brain, and then inject GLP-1, it's not effective in reducing food intake.

• 18:00Andrew D. Huberman?

  Okay.

• 18:00Speaker 00

  The native GLP-1, not a long-acting GLP-1 drug, because that's a different story. They're in circulation longer, can get into the brain. But if you inject the short-half-life native GLP-1, and the animals have a sensory lesion of the vagus nerve, they don't show the food intake reduction. This is work from Wolfgang Longhans in Zurich and his colleagues. They also knock down, using short-hairpin RNA interference, so you can dial down the expression of GLP-1 on the vagus nerve. And those animals have a phenotype, right?

• 18:35Andrew D. Huberman?

  They eat more?

• 18:36Speaker 00

  Yeah, they, I believe, is larger meals.

• 18:39Andrew D. Huberman?

  Gotcha. So that's all consistent that our body is telling our brain when we've had enough, because of fullness of the gut and the presence of enough nutrients have come in. I was going to get to this later, but I think now's the appropriate time, given what you just said. Artificial sweeteners and low-calorie sweeteners are a really big topic online. There's some in my yerba.

• 19:04Speaker 00

  I believe I have some as well.

• 19:05Andrew D. Huberman?

  Stevia, right? So it would be a low-calorie, quote-unquote "natural" sweetener, although there's some manufacturing to take it from a plant to like a drink or a food, but different than like sucralose, et cetera, of course. There seems to be three camps. One is the camp that believes that these things are terrible, that they alter blood glucose, they mess up the microbiome, and that they maybe even cause brain cancer. I mean, people have made that argument about aspartame. I'm not in that camp, but you will see people arguing this. The second group seems to be the ones that just say, look, it's a non-issue, that these are inert in reasonable quantities of consumption. Then there's the third group.

• 19:50Andrew D. Huberman?

  Which I think is quite a few people that kind of wonder like, wow, it's quote unquote "human-made" and like, maybe this stuff isn't good.

• 19:59Speaker 00

  Yeah.

• 19:59Andrew D. Huberman?

  What is the evidence, the research on consumption of, let's lump them for right now, low-calorie artificial sweeteners, on development of appetite, development of the brain, development of the system that you work on, and what does it tell us?

• 20:16Speaker 00

  This is a very controversial topic.

• 20:19Andrew D. Huberman?

  Good.

• 20:20Speaker 00

  And I don't think we have definitive answers in any, to support any of those three camps. So when we consume sweet taste, we have what's called, there's a cephalic phase response, where we're releasing insulin before the nutrients actually get through the GI tract, just from the simple taste of sugar in the mouth. So this is part of our metabolism, right? If you, if this was a sugary drink, you take a sip, you would have some insulin being released to kind of prepare the body, prepare the physiology for that perturbation in blood glucose levels. And there is some evidence in preclinical animal models that if you disrupt the relationship

• 21:01Speaker 00

  between sweet taste in the mouth and the caloric consequences of consuming something, that you can have perturbations in appetite, in glucose regulation, kind of like you're tricking the wisdom of the body, right? So, sweet taste means calories are coming, oh wait, but now it doesn't. And there's not a lot of definitive evidence in humans, there's been randomized clinical trials, generally, I won't, I won't get into all that, but there's no definitive evidence from the clinical trials in humans that it's good for or, or bad for weight loss. There's some evidence in either direction. In the preclinical animal model world, there's some evidence that if you give animals habitual

• 21:46Speaker 00

  exposure to artificial sweeteners, that this will, will disrupt their capacity to metabolize sweet taste later on, and can potentially lead to increased appetite and, and weight gain.

• 21:57Andrew D. Huberman?

  Interesting. So this is early life, daily exposure to artificial sweeteners?

• 22:02Speaker 00

  Yeah. So we, we've done one study in my lab, and I can speak more confidently about that.

• 22:07Andrew D. Huberman?

  Please.

• 22:08Speaker 00

  We had animals who were in the juvenile adolescent stage of development. This is the period of life in which we've studied a lot in, in my laboratory, in terms of dietary factors on adult cognitive processes. And we gave the animals a little bit of artificial sweeteners to consume each day, and we kept it within the FDA's acceptable daily intake levels. So this wasn't necessarily a sledgehammer, it might be something equivalent of six of these a day, something like that. And they consumed it voluntarily, we didn't put it in the drinking water, this was something they liked, they would just get their daily dose and, and carry on. And when the animals were adults, we then tested neurocognitive and metabolic effects of having that exposure during development.

• 22:52Speaker 00

  So at this point, they're no longer getting the, the sweeteners, they're just consuming healthy rodent chow and water. And in this case, we, we found that the animals had some memory impairments, which was an unexpected finding, we don't really know the mechanism for that. But they also had some glucose regulatory changes as well. So if you infuse glucose and bypass the mouth, there's an insulin spike, and the animals that have this exposure showed a larger insulin spike. They also showed changes in the sweet taste receptor expression on the tongue. So we, we found some changes, this is not, not like whopping sledgehammer effects, but

• 23:34Speaker 00

  at least in that model, with, with rodents consuming artificial sweeteners daily during that developmental stage, there is potentially some impact on, on neurocognitive and metabolic processes when they're adults.

• 23:47Andrew D. Huberman?

  Interesting.

• 23:48Speaker 00

  But the caveat is, this is a rodent model.

• 23:50Andrew D. Huberman?

  Sure.

• 23:51Speaker 00

  But we did use three different sweeteners, and it didn't seem to matter which one we used.

• 23:55Andrew D. Huberman?

  Do you recall which those?

• 23:56Speaker 00

  Oh yeah, we had stevia, ACE-K, and saccharin. Saccharin's not one that's common in human beverages and foods these days, but it's one that, that rodents like quite a bit. So a lot of the rodent model, artificial sweetener literature is based on saccharin.

• 24:14Andrew D. Huberman?

  Hmm, okay. Thanks for clarifying.

• 24:16Speaker 00

  Yeah.

• 24:16Andrew D. Huberman?

  I always wondered, when I was growing up, saccharin was always on the table in restaurants, sweeten low.

• 24:22Speaker 00

  Yeah, I think it's one of them.

• 24:23Andrew D. Huberman?

  Yeah. And nowadays, stevia, aspartame, and sucralose seem far more common. I realize it's one study, thank you for clarifying that it's a preclinical, meaning animal study. You mentioned before that you can find data that support the use of low-calorie and artificial sweeteners for weight loss, as well as studies that contradict that. Is there any work that you're aware of that's going to try and reconcile this? Because I feel like they are everywhere now.

• 24:50Speaker 00

  Yeah.

• 24:51Andrew D. Huberman?

  And I don't demonize them, obviously not, I'm drinking one right now. But what's your thought on these? I mean, do you actively avoid them? I mean, you've had a few sips of your drink, so apparently you don't avoid them entirely, but do, would you, given the state of the evidence, recommend people take a step back for young kids consuming artificial sweeteners? Or you, you don't have to give a recommendation, but?

• 25:14Speaker 00

  Yeah, I don't think we have the evidence for, for recommendations at this point. The literature's all over the place, and, and like you were alluding to a minute ago, I don't think that this is going to be solved anytime soon. There's not going to be a randomized clinical trial that's going to figure this out.

• 25:29Andrew D. Huberman?

  Mm-hmm.

• 25:29Speaker 00

  You know, there's some evidence that if you replace habitual sweetened beverage consumption with habitual artificial sweetened beverage consumption, that that could have some beneficial effects on weight loss. But again, there's no reliable trend line where you can say, this, this is good or bad. So I don't know which of the three camps that, that puts me in. But I consume Coke Zero regularly.

• 25:52Andrew D. Huberman?

  Yeah. It's good, yeah, it tastes great.

• 25:54Speaker 00

  It tastes great.

• 25:55Andrew D. Huberman?

  It tastes great. Yeah, so I guess then the takeaway in my mind is, it, people will have to decide whether they want to be in the experimental or the control group, given what, given what they know.

• 26:06Speaker 00

  Right.

• 26:07Andrew D. Huberman?

  Right? Which is kind of the best scenario, people can know that the state of evidence is mixed.

• 26:12Speaker 00

  Yeah.

• 26:12Andrew D. Huberman?

  And somewhat unclear, and then they can place themselves.

• 26:14Speaker 00

  And somewhat, you know, driven by preclinical models, so that's always that, that asterisk caveat.

• 26:19Andrew D. Huberman?

  So, the memory system.

• 26:22Speaker 00

  Yeah.

• 26:22Andrew D. Huberman?

  In the context of food. I'm fascinated by this, because I, I happen to love what most people consider healthy foods, maybe to an unhealthy level. But I realize that some people have this relationship to certain foods, where they just accept that that food, however unhealthy, just needs to be a part of their life in some way. It's kind of interesting. It's kind of how I feel about caffeine. And I wonder if that's memory-based? You know, if, if there's some association early in life or later in life, and the food provides something beyond just comfort. What is the evidence that our memory of a food experience can play an important role in how we frame that food in our behavior?

• 27:06Speaker 00

  Our memory of eating occasions can have a powerful effect on how much we eat subsequently. Let me just give you a couple of examples. So, in one study from Suzanne Higgs and colleagues, they would have people consume a pizza lunch, and then they would have them come in a few hours later, and then they would prime them to really think about the memory of that pizza lunch. In one group, another group was primed to think about something else, I don't remember exactly what the other experimental condition was, but not that lunch. And there might have been a third control group that had no priming. And they were given, they call them biscuits in the UK, but we, we call them cookies, they were given a biscuit cookie taste test, and they would look at whether that memory

• 27:50Speaker 00

  priming had an effect on how much they ate at the, at the cookie taste test. And if they were primed to remember the lunch they had just consumed, they consumed fewer of these biscuits or cookies. So in, in general, the, the memory of recent eating will contribute to eating less at the subsequent eating occasion. There's another interesting study by Jeff Brunstrom and colleagues, where they had, I think it was tomato soup, so it was a bowl that had a peristaltic pump that was either putting more soup into the bowl or pulling it out, but the, the participants were not aware that that was happening. So they saw a certain volume of, of soup, and they consumed the whole bowl, but that

• 28:35Speaker 00

  could have been a mismatch. It could be that they're seeing 300 and they're consuming 500 mls, or they're seeing 500, but they're actually pulling the soup out, so they're consuming 300. So this is a way to manipulate the memory of the meal. How much did you think that you, you consumed?

• 28:50Andrew D. Huberman?

  So sort of a magic bowl of soup, where I'm continuing to eat soup, but the levels are not going down.

• 28:55Speaker 00

  Yeah, or that, or they're going down more than they would just by consuming it. And if you asked them to rate their hunger right after consuming the soup, it didn't matter what they saw, it was based on how much they actually consumed, right? So that, that's sort of the, the wisdom of the body. But then a couple hours later, that, that flipped, and their hunger ratings were more driven by what they saw, what they think they consumed versus what they actually consumed.

• 29:20Andrew D. Huberman?

  Interesting.

• 29:21Speaker 00

  Yeah.

• 29:21Andrew D. Huberman?

  In fact, re, to me, really interesting, because you said, like, the wisdom of the body piece is great, like, you've eaten till you're full, till you're satiated. But then you said the memory of how much one thought they consumed? Impacts what you eat.

• 29:38Speaker 00

  Uh, I don't think the study actually had them eating after that. This was a self-reported hunger rating.

• 29:43Andrew D. Huberman?

  Got it.

• 29:43Speaker 00

  But, you know, presumably it could extend to how much you would eat at a subsequent meal.

• 29:48Andrew D. Huberman?

  So, so much of it seems psychological.

• 29:50Speaker 00

  Yeah.

• 29:50Andrew D. Huberman?

  They, you know, I think we've all experienced like when we're really, really busy. I know there are some people who just seem to eat a lot more during stress. And some people like their appetite just shuts off. They forget to eat is what we say, you know, or they're too busy to eat. Is there any indication that people bin into one or the other category, like people that forget to eat or people who eat when stressed?

• 30:11Speaker 00

  So we, we study how eating impacts memory systems.

• 30:17Speaker 00

  We mammals, when we evolved, we didn't have food readily available, right? You had to compete for, for food resources in a very complicated environment. And a lot of the systems that are traditionally studied for their role in metabolism and appetite and satiation control actually have beneficial effects on promoting memories. And our view is that that makes sense because when an animal encountered nutrients, this is a very important event for that animal. It would be advantageous to remember what was consumed. What were the consequences of that consumption? Can I find this food

• 30:59Speaker 00

  down the road in the future and trying to remember where, where the food was located? So we think that these systems that are responding to nutrients when we eat are actually promoting memory function. Potentially, this is a system that evolved because of how important it would have been to remember these, these eating occasions. These days, maybe less so in modern human environments. You can find a cafe and you don't need to remember exactly where everything is. It's relatively easy to get food. But we think that these, these satiation systems are very much tuned into the memory systems in the brain and, and our focus has been on the hippocampus.

• 31:39Andrew D. Huberman?

  Guessing that your students probably ask you this from time to time, which is, you know, when and what and how much should they eat in order to optimize brain function? That dreadful word optimize, not one I particularly like, but I feel like it's highly individual. I'm most focused when I haven't eaten in a while, up to a point, and I'm thinking about food all the time. I guess that's food noise. And if I eat something and I don't eat too much, I'm good. But if I eat just a bit too much, then I'm sleepy. Like, it seems like energy and focus and memory and learning. I mean, this is, it's kind of a narrow bridge to walk.

• 32:14Speaker 00

  Yeah. And as you pointed out, I think there's a lot of individual differences in this. I always ask my undergraduate class, how do you guys eat? You know, I'm, I'm traditionally three meals a day, but some of them graze all day, never eat a proper meal. Some of them eat one meal a day. And I'd like to assume that many of these individuals sort of fall into what's a sort of a natural eating pattern for them as opposed to being something that's forced on them by their schedule and course demand. But yeah, I don't think there's one recipe for when should you eat, how many times a day, how much? In what's the distance between eating and some kind of mental activity or cognitive demand?

• 32:52Andrew D. Huberman?

  Yeah, it seems like it's worth doing some self experimentation for people to, you know, I mean, the, my read of the, the data on intermittent fasting is that it's one effective way to lose weight, but people can also lose weight by just eating fewer than maintenance calories across three or even more meals. Like, I think for so many years, we got excited that like there was going to be this magic solution to

• 33:15Speaker 00

  Yeah, right.

• 33:16Andrew D. Huberman?

  Eating and weight maintenance, but.

• 33:18Speaker 00

  One of the godfathers of obesity research is George Bray. He was asked, and it was a chapter in a book, but he was talking about what's the right diet. I mean, this is when this was written, there was Atkins diet and all Mediterranean diet and all these different diets and his perspective, one that I for the most part share is that the best diet is one that you can stick to, and that's going to be a different approach for, for different people.

• 33:42Andrew D. Huberman?

  Let's talk more about the memory system because I'm, I'm intrigued by this. So you study not how memory impacts food intake, but how food intake impacts memory.

• 33:51Speaker 00

  I would say we're on both sides of that.

• 33:53Andrew D. Huberman?

  Okay. So let's talk about how food impacts memory. If I want my memory system to be as robust as possible, what should I avoid? Right? We can talk about what to do, but what, what clearly should one avoid besides alcohol, head injuries, you know, opiates and methamphetamine. I think we all agree on that those are bad for memory.

• 34:14Speaker 00

  When I started studying how diet impacts neurocognition and memory function, we were working with adult animals and we were using what we refer to as a Western diet. So this is a diet that maybe 35% of calories from fat, 15% coming from sugar. And, and a lot of that's simple sugar. So, you know, simple sugar carbohydrates, not, not complex starch carbohydrates. And that in animal models can lead to hippocampal dependent memory impairments. If the animals are on this diet for even, even like a week, but generally these studies take a few months and the hippocampal dependent memory

• 34:55Speaker 00

  processes seem to be more susceptible to the negative impacts of these diet than other kinds of memories that don't rely on hippocampus. So the hippocampus is somewhat of a canary in the coal mine. And when I started my lab at here in Los Angeles, we were looking at development. So shifting away from adult models and looking at if you give animals individual components of a diet during the juvenile adolescent phase of development, is there a longer term impact on their memory systems? And the first model we were studying was a high sugar model. So the animals basically had ad libitum access to a sugar solution, about the same percentage of calories

• 35:38Speaker 00

  as a, as a soft drink that we consume. And otherwise they had healthy food and water. And with this model, the animals show hippocampal dependent memory deficits when they're older. And these seem to persist later into life, even though they're not consuming the sugar anymore. So we, we had a few studies with that model. There may be a role for the microbiome. There's some changes in, in the bacteria in the gut from the sugar model that, that may have a functional connection to the memory impairments. We've also looked at models where the animals are consuming like a total junk food diet to try to look at, at mechanisms.

• 36:18Speaker 00

  But again, it's the same kind of thing. So if the animals consume a junk food diet, so we give them chocolate peanut butter cups, ruffled potato chips, rodent, high fat, high sugar diet. They show these memory impairments that last even after you switch them to a healthy diet. That's not to say that we couldn't reverse these memory impairments with some kind of other intervention, other than just putting them back on a healthy diet. But at least in rodents and during this developmental window, these kinds of foods have a long-term impact on neurocognition. We have a preprint, it's which is not a peer reviewed publication yet. It's sort of in, in the process of becoming that, hopefully someday. Where we were trying to look at food processing from a mechanistic

• 37:04Speaker 00

  individual variable perspective. So in food processing is a term we all hear. Alter processed foods. The way this is studied in humans is there's this NOVA classification system where you have four different categories of food processing where the alter processed food is basically just, you know, shitty food. And then the, the other end of the extreme is, you know, perfect raw vegetables and completely unprocessed food. And that's not really mechanistic in terms of what types of processing matter, because food, food processing, there's a lot of processes that happen to, to food in modernized food industry. So we wanted to try to take it one variable at a time. And we ended up heat treating the food.

• 37:49Speaker 00

  So this is an otherwise healthy food and we baked it for an hour at, at a high degree, high temperature. And the idea behind this is that induces something called the Maillard reaction. The Maillard is used in cooking because it enhances the flavor of food. So this is something that we do for a reason. This is a chemical reaction that happens depending upon the, the nutrient composition, the pH, a lot of factors. But when you heat treat food, you can get this, this Maillard reaction.

• 38:16Andrew D. Huberman?

  Do you want to just describe the, the subjective experience of it? Like if I took a carrot and I just ate it, most people know what that tastes like. But my, if I took that carrot and I sliced it and basted it with some butter, maybe a little bit of olive oil, some salt, and I stuck it in the oven and cooked it until it was soft, it come out, it has almost like a meat like quality to it, taste that it's a little tangy, but savory. Is that, that's what you're referring to?

• 38:47Speaker 00

  Yeah. Yeah. I mean, the, the actual flavor components that are a result of the Maillard reaction are not, not well understood. So we, we can't point to certain flavonoids and say that, oh, this is, it's making it taste like this. But in general, you know, if you, if you bake a casserole, it's going to taste better than before you baked it, right?

• 39:06Andrew D. Huberman?

  Yeah, Lord knows.

• 39:07Speaker 00

  So we were trying to, to create this chemical reaction in otherwise healthy food. And what happens when you heat this food up is there's chemical byproducts of this process. They're called advanced glycation end products. The acronym is A G E, ages. And these chemicals are actually in our normal physiology. So we have A G E circulating. We have receptors for A G Es. It's the rage receptor, which is a pretty cool name for receptor. And this system is, it's generally associated with diabetes and aging and things that we don't think are great, great things. And when you. Heat food, depending upon the chemical composition of the food, the temperature, et cetera,

• 39:51Speaker 00

  you get these AGEs that are introduced into the food itself. So we're basically looking at if animals consume this age-enriched diet, is what we were calling it during development, is there an impact on cognitive processes when they're adults? And it turns out, again, just the caveat is this is unpublished work, but a pre-print, is that we see memory impairments with this age-enriched diet. We think that there may be a role for the microbiome. There was a population of bacteria that was eliminated through the heat treatment process. And when we reintroduced it to the animals, we were able to reverse these memory impairments.

• 40:30Andrew D. Huberman?

  When you say memory impairments, could you describe the type of memory impairment?

• 40:36Speaker 00

  Yeah.

• 40:36Andrew D. Huberman?

  And I'm not trying to review your paper, but are these big effects? I mean, they're obviously statistically significant, or you wouldn't be describing them the way you are. But just to frame in our minds, I mean, are these animals, can they remember where something was placed and come back to it later? Or is it sort of like getting into challenges with higher order memory?

• 40:56Speaker 00

  We use a variety of memory procedures in our labs. Some of the more common ones is we have a maze, actually about the size of this table, where there's holes on the edge of the maze, and the animals are using visual spatial cues surrounding the maze to remember where things are located. This is a hippocampal-dependent type of spatial learning and memory. And we've done different versions of this, but generally, they're trying to remember where food was consumed. So they crawl into a little tunnel, they eat a meal, and then the next day, we ask them, do they remember where that tunnel is? We also do memory tasks that do not involve food, where the animals are placed in an arena, and they have to remember which objects they've seen and which locations before.

• 41:41Speaker 00

  It's kind of like a, okay, I've seen this object before, but if I haven't seen it in this new location, the animal will preferentially investigate that object. These are just some of the examples of hippocampal-dependent memory tests that we use. In terms of effect size, that's a little bit tricky. I mean, I'm not saying that it's the equivalent of having a lesion to that brain region, but in some of these memory tests, you have above-chance performance, and then you have not that. And generally, we see the controlled treatments will have above-chance performance, giving us some indication that the animals remember above chance where that food was located or which object they've seen in which location. And with some of these diet manipulations,

• 42:26Speaker 00

  the animals are performing basically at chance. So they're not showing us any evidence that they remember where they got the food from before.

• 42:33Andrew D. Huberman?

  I'd like to take a quick break and acknowledge our sponsor, AG1. I'm excited to share that AG1 has just launched their newest formulation, AG1 Pro. AG1 Pro takes the clinically-backed AG1 formula, which is a blend of vitamins, minerals, probiotics, and adaptogens, and adds three important new ingredients: creatine monohydrate, calcium HMB, and zinc carnecine. Each serving has five grams of creatine monohydrate to support muscle strength and performance, as well as brain health; calcium HMB to support muscle recovery and reduce muscle breakdown; and zinc carnecine to support and improve the lining of your gut. All three of these ingredients have compelling science to support them, and therefore, I love seeing them added to the existing AG1 formula. As most of you know, I've been taking AG1 every day

• 43:17Andrew D. Huberman?

  for nearly 14 years now. I started taking it long before I even knew what a podcast was. It's a great product, and it's now made even better with the new AG1 Pro formula. If you would like to try AG1 Pro, you can go to drinkag1.com/huberman to get a special offer. AG1 is giving away a free bottle of Omega-3 Coenzyme Q10 with your first subscription. Again, go to drinkag1.com/huberman to get a free bottle of Omega-3 Coenzyme Q10 with your first AG1 subscription. I don't want to make too much of the findings, nor do I want to place you in the position of feeling like you have to, but I'm intrigued by this result because for the last five years or so,

• 43:57Andrew D. Huberman?

  there's been this unofficial naming of Alzheimer's-like dementia as type 3 diabetes, which I know drives certain physicians and neurologists absolutely bonkers because that's not an official diagnosis term. But I think we do, on the other hand, now well appreciate that diet impacts the brain and that really disrupted metabolic function, like chronically elevated insulin due to elevated blood glucose from either food intake or otherwise, is problematic for the brain. And as a consequence, a lot of people in the spheres that I find myself in these days

• 44:37Andrew D. Huberman?

  are trying to offset their potential memory loss in the future, or even treat the memory loss of their parents or spouse by saying, hey, look, at a minimum, we can control food intake. Might not be a cure, but, you know, some are trying ketogenic diets, for instance. Some are trying to manage blood glucose using metformin or berberine, neither of which I do, I should be clear. Some are taking even more aggressive measures. And now there's the discussion about the GLPs. It's like, maybe these will improve longevity of brain function or improve memory. So I don't think it's too much of a leap to just chop it up around this topic.

• 45:18Andrew D. Huberman?

  And just with the caveat that you're not talking about specific data, what are your thoughts on this? This notion that maybe some major component of age-related dementia, maybe even Alzheimer's, is earlier in life or current food intake-related?

• 45:34Speaker 00

  Yeah, there's pretty strong evidence from perspective studies. I mean, there are correlations, but from perspective studies showing that midlife dietary patterns and metabolic status can be associated with an increased risk of dementia later in life, including viscerataposity. So the connections appear to be there. In animal models, we have transgenic models of Alzheimer's, where animals have gene mutations that lead them to, at a later point in their life, develop symptoms that are analogous to human Alzheimer's. And in the preclinical world, there's evidence that consuming a Western diet, so again, a high percentage of calories from fat

• 46:18Speaker 00

  and simple sugars can exacerbate that pathology, can essentially lead the animals to develop the symptoms of that Alzheimer's in this transgenic model earlier than they would if they were consuming a healthy diet. So the connections are there. I think it's more prospective than something you can deal with once symptoms arise. I don't think that... I think it's more important to have a healthy dietary pattern throughout life, as opposed to, once there's a problem, you know, switching at that point.

• 46:52Andrew D. Huberman?

  Yeah, so it's sort of the, and here I am, heavily joking slash stereotyping, sort of like, were you raised in West Los Angeles, where everyone's talking about eating healthy all the time? It's like a major topic of focus. Are you from an area, like, an area of the country where nutrition isn't prioritized? Or are you sort of like most people, where grew up eating some healthy foods with a mix of some ice cream and pizza? And a little bit of alcohol for most, you know? Like, I mean, most people are in this kind of mishmash, and yet, we see people with Alzheimer's who are dealing with metabolic dysfunction.

• 47:36Andrew D. Huberman?

  And we see people who get Alzheimer's who otherwise look healthy. I don't see how we can draw a one-to-one correlation between...

• 47:43Speaker 00

  No, we definitely can.

• 47:44Andrew D. Huberman?

  Food.

• 47:44Speaker 00

  Yeah. Yeah, there's correlations, but it's not a direct line.

• 47:50Andrew D. Huberman?

  It seems these days that people just feel really good talking about the fact that exercise is one of the few things we can do to maintain or improve brain function. I'm not aware of any studies showing that exercise actually makes people smarter. I think it places the body and brain in a position to go learn and get smarter, or to hold on to what they've got. But the question I can't seem to find an answer to is, are the positive effects of exercise on cognition and memory, are they the consequence of improved metabolic function? End of story. Or is there something else there?

• 48:25Speaker 00

  I think the answer is probably both. Getting back to this diet model in rodents, where we have a Western diet, there is some evidence that exercise can reverse those memory deficits. And in part, that's happening through changes in the brain.

• 48:42Andrew D. Huberman?

  Interesting. So for the animals that were fed an unhealthy diet, let's just call it, and then later are put on a healthy diet and exhibit these longstanding memory deficits, if they exercise, they can rescue those deficits?

• 48:54Speaker 00

  That's been shown in rats, yeah.

• 48:56Andrew D. Huberman?

  Interesting. And I recall, I never worked in this area, but that one could do a memory test where you actually have the animals swim to find a platform?

• 49:06Speaker 00

  Or swim.

• 49:06Andrew D. Huberman?

  So does the exercise have to be related to the memory task itself? Or can they just run on a wheel, and that rescues their memory?

• 49:14Speaker 00

  Well, there's treadmill models, and there's wheel-running models of exercise in rodents. One of the reasons that we don't use the procedure you were talking about is it's stressful for the animal. They don't like being thrown into water, and there's a physical demand, you know, to swim. And so we try to avoid that particular task, where the exercise capacity of the animal has any input at all into their performance.

• 49:40Andrew D. Huberman?

  We're talking about here sits right at the edge of like where modern brain health and longevity care is at. It's like, on the one hand, we're talking about like what one eats, whether one exercises and brain function. But to my knowledge, there's nothing else known about Alzheimer's that tells us to do something specific besides also trying to be a lifelong learner and social connection. Okay, those are critical too, obviously. But there's tons of stuff, it seems, that can impair the system. But we actually have in hand very few things besides exercise, quality nutrition, social connection, and ongoing curiosity to try and maintain brain function. I realize this isn't your specific area of focus, but when you look

• 50:25Andrew D. Huberman?

  out on the landscape of dementia and Alzheimer's research, preclinical or in humans, like you've spent some time in the hippocampus as a researcher, like, do you think we're going to get to the place where what we call Alzheimer's is a reflection of a bunch of bad choices, plus some genetic preloading of the system, some susceptibility that might be heightened in some people? Or do you think there's really a disease that that is independent of all that?

• 50:54Speaker 00

  We haven't come very far in terms of finding effective treatments for Alzheimer's, as I'm sure you know. And one thing that that we've been doing in my lab is to try to think outside of the box and try to think about how the gut might be connecting to this pathology, as opposed to just looking at what chemical processes are changing in the brain. One example of that is we've done some work with with the vagus nerve, I think I mentioned earlier, and if you lesion the vagus nerve, as it's coming out of the gut, the gastrointestinal innervating components of the nerve, animals show hippocampal dependent memory impairments.

• 51:36Speaker 00

  So there's a connection between the vagus nerve and the hippocampus, and we're interested in trying to understand, is that connection relevant to Alzheimer's and dementia pathology? We don't know yet. There was one study in a population in Taiwan that in the 1980s, maybe a little bit into 90s, people would get vagotomies. So they would get a truncal vagus nerve lesion for stomach ulcers. That was a somewhat common treatment at the time.

• 52:07Andrew D. Huberman?

  Medicine loves to start with a sledgehammer.

• 52:09Speaker 00

  Start with a sledgehammer.

• 52:10Andrew D. Huberman?

  You got ulcers, let's give you a vagotomy. Let's cut the major connection between the brain and body. Oh goodness.

• 52:15Speaker 00

  And it was effective for that. But what's what's interesting is we have in other countries, not so much the US, they have impeccable medical records that are kept for decades. And you can look at, okay, if an individual had a truncal vagotomy for stomach ulcer, what's the probability of developing dementia later on? And there does seem to be in one small study, a positive correlation. So there may be some risk factor for for vagotomy in humans and developing Alzheimer's of some kind, some kind of pathology later on. We're interested in looking at that in a different cohort in a Swedish national registry, looking

• 52:57Speaker 00

  at whether we can kind of dig in a little bit deeper and and find out whether there's any risk in humans of having vagus nerve disruption and Alzheimer's pathology. In animals, we can study this a little bit more directly. So we have a transgenic Alzheimer's model in a rat. So they basically developed the amyloid and tau pathology in the hippocampus in an age dependent fashion. So when they're older, pretty decent model as far as these things go. And we have devices that are called Vagus nerve stimulation devices. And we can implant them. There's different kinds of VNS devices. The one that we're working

• 53:38Speaker 00

  with, it relies on mechanical distension and contraction of the stomach. So it's basically sutured to the stomach, and it only sends a stimulation, electrical stimulation to the nerve when the animals are eating, because that's when you get the natural expansion and contraction of the stomach. And we're interested in knowing whether these devices can, I don't want to say eliminate the Alzheimer's pathology, but potentially improve the outcome in these animals. That's something that's ongoing. Right now, we have shown that these devices can rescue the memory impairments from an unhealthy diet. So we think there's some kind of functional benefit, potentially of Vagus nerve stimulation in in models of

• 54:21Speaker 00

  memory impairment, but still in the baby stages of trying to figure that out.

• 54:25Andrew D. Huberman?

  I can make up a simplistic story in my mind that I'm sure is only partially true, if at all, but it goes something like this, that the memory systems of the brain, which clearly involve the hippocampus, that's not debated, evolved first to keep us alive, as opposed to make us remember, you know, sweet memories from first junior high school dance, because that was really awesome. I'm just kidding. And that nothing is more fundamental to survival than our ability to keep ourselves nourished and hydrated from day to day. So that a huge component of our hippocampal function is nested in our gut's ability to

• 55:09Andrew D. Huberman?

  communicate with our brain, hey, these nutrients came in at this timing in this amount, in the context of a bunch of other things. Like, I feel like most neuroscientists would agree, and you work on this system. So I think, am I on solid ground there?

• 55:24Speaker 00

  Yeah, and not just the vagus nerve either. We saw the vagus nerve, but also if you look at at hormones that are involved in appetite and metabolism that get into the brain, like insulin and ghrelin, there's a lot of receptors for these hormones in the hippocampus. So that seems to be an alternative pathway through which the hippocampus is getting insight into the metabolic state of the animal through these circulating humoral signals, like leptin is another one, that gets into the brain from circulation. It's really receiving the neural connection from the vagus nerve, but also the humoral sort of longer term energy status connection from these hormones. It's similar in many ways to the hypothalamus in

• 56:09Speaker 00

  terms of the receptors that are expressed there. And of course, the hypothalamus is the classic feeding center in the brain. That's where these AGRP, palm seed neurons are that I know you've discussed previously. That's the traditional feeding center, but we've been for a number of years now, been making a case that, hey, the hippocampus is really important for this too. And feeding, eating appetite is not a reflexive response. It's very complicated. It's a very complex decision that has to be made when an animal decides whether to forage, where to forage, you know, what to eat. These are not not simple behaviors. So it, to me,

• 56:49Speaker 00

  it makes a lot of sense that these complex behaviors are not exclusively being mediated by these brain substrates that are thought to to control more basic homeostatic regulatory processes like the brain stem and hypothalamus, but you also have these higher order inputs that are very much tuned into this behavior as well.

• 57:09Andrew D. Huberman?

  So here's the model, simplistic model I'm coming up with in my head, that the hypothalamus has these switches, find food, eat, stop eating, et cetera. And we pretty much know what those switches are, the location of the neurons and so on, because of the work of you and excellent colleagues in the field. And then there's this other system that we've been talking about, that's a major topic of focus, this body to brain, vagus to hippocampus kind of memory system. And it's so interesting that, you know, when an animal or a human doesn't eat well, meaning enough macronutrient, sure, most people are getting enough macronutrients,

• 57:52Andrew D. Huberman?

  at least in this country, I realize there are exceptions, but but not enough micronutrients, not enough of the essential fatty acids, the vitamins and minerals, the protein relative to the calories they're taking in. When that ratio is skewed in the wrong direction, then the memory system suffers. And so if we adhere to the adage, use it or lose it, right? I kind of getting this picture after all these years in neuroscience, that like, our brain develops and our parents and we do as well as we can. We don't control everything at the beginning, and then we do that as well as we can, then we sort of land in this early stage of adulthood of like mid 20s, 30s. And then our goal is to hold on to what we have and improve on it if we can, right? I mean, there's nothing, you know, new about

• 58:35Andrew D. Huberman?

  the statement I just made, but that the gut is constantly updating, like, the body is getting what it needs. Therefore, if you're a neuron in the hippocampus, you can basically stay functional and alive. Otherwise, it sounds like neurons start caching out. They might not die entirely, but I mean, this is a different picture of nutrition that I think is so important. And I think it fits well with what we're learning about dementia and Alzheimer's, that there is this blood sugar, but also nutrient related aspect to it. So if this system from the body to the brain is is really a core feature of keeping memory online, and maybe even making it better, without feeling the need to make specific

• 59:20Andrew D. Huberman?

  recommendations, how do you personally think about this in the context of your own food intake? Is it like, okay, eat well, but not too much, we know that. But what do you think about doing that could keep this system robust? Because presumably, you want to do that. I realize, and I want to be very clear, I'm not asking you to make recommendations, but you're more versed in this perhaps than anyone I've ever spoken to about this body-brain connection as it relates to memory and food intake. So I'm just curious where your mind is at. And bracket it as many times, as many caveats as you need to feel comfortable, but I'm curious, and I'm certain many other people are curious.

• 59:55Speaker 00

  I don't make specific recommendations about what people should or shouldn't eat, but I do share our results with with people who have kids who may be thinking about, you know, what do I feed my kid? And I always make the very important caveat that we're studying rodents. We think are a good model for for memory systems, for for energy metabolism. They are a good model for humans, but it's a very important caveat. That said, there is evidence in humans that supports some of what we are doing in rodents. So, for example, Dick Stevenson and colleagues did some studies in healthy adults. So this is undergrad students age approximate,

• 1:00:36Speaker 00

  and looked at their habitual dietary patterns and then how well they did on hippocampal dependent memory tasks. So these otherwise healthy adults are not diabetic, really just normal, healthy young adults. There was connections between habitual sugar consumption and saturated fatty acid consumption and how well they did on these memory tests. That's not to say that these can't easily be reversed by consuming a healthier diet. But I do think it's worth looking into what we know in humans, which is very little because humans unfortunately aren't that good at reporting what they actually eat. This is a major limitation in doing these kinds of studies with rodents. We control what they eat, we measure it, we have 100% near 100% accuracy of what they're eating and how much.

• 1:01:21Andrew D. Huberman?

  Even with phones nowadays where all they have to do is take a picture?

• 1:01:24Speaker 00

  It's improved it, yeah.

• 1:01:25Andrew D. Huberman?

  Is that they lie or are they just too lazy or are they?

• 1:01:28Speaker 00

  I don't, I don't want to say it's that, but it's just not an accurate process to date. I think having the the apps involved are going to make it a little bit better. There's caveats with both the animal model research because the rats and the human research, because we don't have a lot of control about what they're eating and how accurate their reporting is. But that said, there does seem to be evidence in humans to support what we're doing in in rats. So I guess that not making precise dietary recommendations, but excess sugar not good. Excess saturated fatty acid is not good.

• 1:02:08Andrew D. Huberman?

  I wonder why we've gotten so good at process, creating quote unquote, highly processed or even partially processed food that's designed to taste really, really good. So people consume more of it, independent of its micronutrient and other value. Why can't we engineer foods that have robust amounts of micronutrients? Like, I just think this would be a great thing, and parents want their kids to be healthy and adults want to be healthy. I don't think anyone wants to feel sick. So provided it was safe, I would love to eat a bowl of blueberries that had like 10 times as many polyphenols. I would pay more for those blueberries. I don't know how much more, I guess it would kind of depend.

• 1:02:52Andrew D. Huberman?

  But it seems that the engineering can be used to push the quality of food in either direction. And I don't understand why this isn't happening. And people will say, oh, because they just want you to buy more and more. Okay, that's true, but you can still keep food tasting good, very good, in fact. So why aren't people engineering better, more nutritious food?

• 1:03:14Speaker 00

  As you're alluding to, I think the the technology is there. I think it's just the the sea change hasn't happened in terms of where the demand is, where the production is. I'd like to think that a sea change is possible. I mean, the the food industry is over 60% of calories that not, maybe not you or I, but like many people consume come from ultra-processed foods in the US. So that's a lot, over 60%. And that's a direct product of largely that the food industry producing these kinds of foods. What you're saying sounds great, like if there's a sea change in demand or some other top-down regulatory change in the food industry.

• 1:03:57Speaker 00

  Yeah, I think I think that's certainly a optimistic perspective.

• 1:04:01Andrew D. Huberman?

  Because even if people aren't eating enough fruits and vegetables, if you can spike it otherwise unhealthy diet with like two pieces of fruit a day and one vegetable, which is not what, you know, sufficient. But if you overload those with more micronutrients, it just seems so straightforward to do.

• 1:04:17Speaker 00

  Yeah.

• 1:04:17Andrew D. Huberman?

  I mean, clearly, the ultra-processed food industry has hacked the get people to desire more piece as well as the marketing piece to drive it through like cartoons and clever marketing and celebrity marketing and this kind of thing. It just seems obvious to me now. There's also an issue, and I'd love your thoughts on this, in the in the science field itself. I mean, years ago, I used to occasionally come across an article in a journal of neuroscience, which, you know, back then, I think still now is a respectable journal. It would be like, blueberry intake correlated with improved cognition in rats. You'd occasionally see that. But I noticed that that kind of work got pushed aside. There seems to be more of an emphasis on finding relationships between the bad stuff and deficits. And which I think is essential, but I

• 1:05:01Speaker 00

  And I'm very, very much guilty of that, too.

• 1:05:04Andrew D. Huberman?

  Well, and and I know, I think it's important work, but I feel like loss of function and sort of, well, gain of function is kind of a loaded term now, but it just means like things that push things in the potentially in the other direction.

• 1:05:15Speaker 00

  Part of the problem with what you're getting at in the preclinical world is a standard rodent diet is very healthy, right? This is like 10 to 15% of calories from fat. The the carbohydrate source is complex carbohydrates. So we're kind of starting with incredibly healthy baseline. That's not to say there's not more room for looking at certain extracts, supplementation, and whether they can have beneficial effects. But with the standard rodent diet, the animals are they're not showing memory impairments on that. Does that make sense? It's sort of easier to make something go wrong than to take an already healthy baseline and and improve upon it.

• 1:05:55Andrew D. Huberman?

  Yeah. I mean, I think it's, I'm not going to blame science for this, but I feel like in some ways that's what led to this proliferation of like diet books, and this is the way to, you know, make your brain healthy. This is the way, because there was just, there was a lot of empty space for people to step in, and there didn't need to be any kind of formal structure that they had to obey. So in some sense, it's like the landscape was perfect for that.

• 1:06:19Speaker 00

  Lacking a strong scientific literature in this area, anything goes, right?

• 1:06:23Andrew D. Huberman?

  Right, right. Because I think by now we all know what we shouldn't do.

• 1:06:27Speaker 00

  Yeah.

• 1:06:27Andrew D. Huberman?

  And we, and most, many people try not to. There's also, I've been reading about this, that with the advent of the GLPs, we are entering perhaps the first time in nearly 75 years where we might start to see thiamine deficiencies and micronutrient deficiencies in a like fully modernized culture, because people aren't eating enough. And when they are eating, they're saying, oh, you know, I'll just have like a little bit of this donut, have a little bit of this salad. And, you know, salad, most places doesn't actually provide that in nutrients. Probably the salads that you make or that you can buy at a really good market, you know. But if you look at like most salads, like a couple of people, pieces of iceberg lettuce, like slices of cucumber tomato, like that's not, that's not what we're talking about.

• 1:07:11Andrew D. Huberman?

  We're talking about getting sufficient fiber and vitamins and minerals, right? So it could be that we end up with a a large population of people who are kind of skinny fat because of the loss of muscle with the GLPs. They're not exercising, plus micronutrient deficient. And in terms of hippocampal function, it seems like that would be maybe as bad as as obesity.

• 1:07:37Speaker 00

  That's not a concern that I have, but part of the reason for that is that people don't take, in general, they don't take these GLP-1 drugs for a long period of time. A majority will discontinue treatment within two years of starting.

• 1:07:51Andrew D. Huberman?

  Because of side effects or cost.

• 1:07:53Speaker 00

  Because of the side effects, another reason for discontinuation in elderly populations. There's lean mass loss, which is, I'm not saying that the GLP-1 drugs preferentially reduce lean mass, I'm not saying that at all. But there's, when you lose weight, you lose both fat and lean mass. So that's another common use for discontinuation. But people just aren't staying on these drugs long enough to really have, I mean, to my knowledge, there's never been micronutrient deficiency issues in any of the clinical trials, which that's most of what we know is from those clinical trials.

• 1:08:26Andrew D. Huberman?

  Those are about a year or two, as I recall.

• 1:08:27Speaker 00

  Yeah, typically, but

• 1:08:30Speaker 00

  Those trials are done in individuals. Everything's controlled, diabetic and/or obese. Now, it's a whole new world out there where people can get their hands on these that don't need them. So I think there are a lot of potential issues with GLP-1-based drug use in lean individuals that we just don't have any grasp on because we haven't done those clinical trials and probably won't.

• 1:08:55Andrew D. Huberman?

  It's almost like a perfect storm. Like, in a country, the United States, where healthy eating has never been a theme, if I'm honest. You know, it's just not. As a parent from South America, it's like the foods they champion are healthy foods. Overabundance of meat, admittedly, in Argentina, but like, the idea is like, people from Eastern Europe will talk about like, their comfort foods are often very healthy. They have a lot of nutrients in them, like, south of France and Scandinavia. And Americans will roll their eyes. They're like, oh, you know, but it's a reality that, you know, fried chicken, pizza, cotton candy, hot dogs, apple pie, these are like the American corn, these are the American foods.

• 1:09:40Andrew D. Huberman?

  And so, in the absence of a complete revision of how we think about food and health, I feel like what's needed more than ever is, people need to be educated on what to eat to keep their brain healthy. Like, it's one of the most common questions I get, and I end up having to revert to like all the other, like, exercise, sleep, and all the other stuff. You can give answers, protein, fruits, vegetables, but my observation is that some people will do that, and many, many people are just, they're looking for a pill or a solution. And the GLP seem to have provided a solution, at least to the weight piece. But it doesn't seem that they've provided a solution to the nutrient piece. And that has me concerned, frankly.

• 1:10:21Speaker 00

  Any weight loss program should have some nutrient and physical activity components embedded in that program, right? Simply taking a pill is not the optimal way to lose weight. And the clinical trials where we have data from, there is nutritional guidelines and physical activity guidelines embedded within those trials.

• 1:10:42Andrew D. Huberman?

  They are having them exercise.

• 1:10:44Speaker 00

  Most of them, yeah. I can't say every single one, but yeah.

• 1:10:48Andrew D. Huberman?

  I mean, this is one of the most common sets of questions that I get around the issues we're talking about today, just incidentally, like, should I be taking GLPs? Like, what about, you know, what should I eat when I'm taking a GLP? Can I microdose it? Can I go off it? What about the muscle loss? You know, it's like, I think this is going to be a major theme for the next five to 10 years. And that's in adults, so to say nothing of the questions about kids and GLPs. I don't know that there are any data on GLP's drugs in younger populations. I'm sure there are, but I'm not aware of them.

• 1:11:22Speaker 00

  I'm not deeply familiar with them, but I believe that semaglutide may be FDA-approved in some populations of teenagers, but I don't remember the specific parameters for that.

• 1:11:33Andrew D. Huberman?

  I'd like to take a quick break and acknowledge one of our sponsors, Element. Element is an electrolyte drink that has everything you need and nothing you don't. That means the electrolytes, sodium, magnesium, and potassium, all in the correct ratios, but no sugar. Proper hydration is critical for brain and body function. Even a slight degree of dehydration can diminish your cognitive and physical performance. It's also important that you get adequate electrolytes. The electrolytes, sodium, magnesium, and potassium, are vital for the functioning of all cells in your body, especially your neurons or your nerve cells. Drinking Element makes it very easy to ensure that you're getting adequate hydration and adequate electrolytes. My days tend to start really fast, meaning I have to jump right into work or right into exercise.

• 1:12:17Andrew D. Huberman?

  So to make sure that I'm hydrated and I have sufficient electrolytes, when I first wake up in the morning, I drink 16 to 32 ounces of water with an Element packet dissolved in it. I also drink Element dissolved in water during any kind of physical exercise that I'm doing, especially on hot days when I'm sweating a lot and losing water and electrolytes. Element has a bunch of great tasting flavors. In fact, I love them all. I love the watermelon, the raspberry, the citrus, and I really love the lemonade flavor. So if you'd like to try Element, you can go to drinkelement.com/huberman to claim a free Element sample pack with any purchase. Again, that's drinkelement.com/huberman to claim a free sample pack. Let's say that you had an enormous vault of funds to do research on anything in this

• 1:13:01Andrew D. Huberman?

  system, or any other system for that matter. If you ever played that experiment, it's just too painful to think about giving today's...

• 1:13:07Speaker 00

  It's a little painful. Unless you're offering the vault.

• 1:13:11Andrew D. Huberman?

  No, but if you could do any experiment here, like, didn't have to write a grant to do it, and you felt like, what would that experiment be? Like, what do you think is really needed in this field to start to really connect the dots? Or just that you think would be a fun, entertaining experiment? Because, let's face it, scientists like to do experiments also for fun.

• 1:13:31Speaker 00

  In many ways, I'm lucky that we are doing some of those experiments now. Like, the example I gave earlier with the Vagus nerve stimulation device in this transgenic Alzheimer's model, that's what I want to be doing. Try to think about how the gut might be, not just connected to the pathology, but potentially understanding that connection can lead to novel treatments that haven't really been considered or applied before. We are working on what I would like to be working on, which is, in some ways, it's a benefit of the NIH funding model, that you have flexibility in what you study. Of course, you put a proposal in, and it's reviewed, and if you're lucky enough to get the funding, you're doing a lot of what you intended to do, but you're able to have

• 1:14:15Speaker 00

  a little bit of flexibility, and, oh, we found this unexpected result, so we're going to go this direction with it. So, yeah, I'm very fortunate to be doing what I want to be doing in the lab these days.

• 1:14:29Andrew D. Huberman?

  I'd like to know more about the nature of the signal from the vagus to the hippocampus. I mean, these days, most people who've heard of vagus think about it as a calming pathway. They've heard about humming or long exhale breathing, which is a different branch of the vagus. That's all still true about calming the body, but my understanding is that the ascending, from the body up to brain, vagal connections are mostly excitatory, they are mostly about creating more arousal in the brain, not more calm. And I think that confuses a lot of people, but my friends who do neurosurgery tell me that if a patient is, you know, maybe drifting under a bit, you can do vagal stimulation to make them more alert again. So clearly, there's something there.

• 1:15:11Andrew D. Huberman?

  So I'm curious what the nature of the signal from the gut to the brain is? Is it like, we have food, we have nutrients, and that's sort of a bunch of gates? Like, if you have enough fatty acids, enough protein, enough glucose, then three gates have to be open, and then boom, there's a signal? Because the gut, I think even for neuroscientists, we tend to forget that the gut doesn't go, hey, we just ate this amazing lentil soup. It's just, the lentil soup has an effect, and then electrical currents get sent up. And the signals in my mind are kind of crude. And so, is it that then a bunch of excitation is released in the hippocampus, and now you can keep the neurons alive, because excitation is good for neurons? Is that like, kind of the picture?

• 1:15:54Speaker 00

  It's not one common signal, right? So there's mechanoreceptors in the stomach, and they're picking up on distension of the stomach when food is in the stomach, and that's a vagal signal, but that's distinct from chemo receptors in the intestines. So you get this sort of different timing of different signals as the meal is being... It's not as if there's just this unified electrical signal that's coming to the brain, and the neurons of the vagus nerves and the nodosganglia, they express different receptors. They're very heterogeneous. They're not all the same kind of neuron responding to the same thing. We don't know a lot about, you know, what the signal is when it gets to the brainstem, but we do know that there's many different things that are contributing to that signaling

• 1:16:39Speaker 00

  pathway. So I don't think about it as just one unified, hey, we've eaten. It's very nuanced.

• 1:16:46Andrew D. Huberman?

  So it's a song, not a gong?

• 1:16:48Speaker 00

  Yeah, exactly. We've identified how this information gets to the hippocampus. So from the brainstem, there's an input to the medial septum, and then there's a acetylcholine-producing neurons in the medial septum are then innervating the hippocampus. So it's kind of a three-tier pathway through which the gut, at least from the vagus, this information's getting to the hippocampus. So acetylcholine is the currency that we've been studying most recently in this gut-brain- hippocampus axis.

• 1:17:20Andrew D. Huberman?

  Interesting. Maybe we could drill into that a little bit, because we had Michael Kilgarde on the podcast, who, if people haven't seen that, he trained with the Mike Merzenick, kind of like one of the granddaddy, modern granddaddies of adult neuroplasticity. And the data on increasing acetylcholine and the effects on adult plasticity, to me still, after all these years, having spent so much time in that literature, are still kind of jaw-dropping. Like, if you get acetylcholine levels in the brain acutely elevated, you un-gate...

• 1:17:53Andrew D. Huberman?

  Incredible plasticity, which is not to say people should go to use nicotine. By the way, if you're thinking about using nicotine, folks, if you use nicotine every day, you actually blunt the system.

• 1:18:03Speaker 00

  Right.

• 1:18:04Andrew D. Huberman?

  You reset the threshold. This is why it's technically only a cognitive enhancer if you use it every once in a while. So like I just want to put that out there because otherwise people will be looking up how to spike the system. But I'm really interested. So what is the acetylcholine doing for the hippocampus when the gut sends this song of, hey, we've got these nutrients? It like, what is the nature of that signal?

• 1:18:28Speaker 00

  So using fiber photometry recording, we can look at the activity of neuromodulators like acetylcholine when the animals are awake and doing something like eating a meal.

• 1:18:40Andrew D. Huberman?

  Cool.

• 1:18:41Speaker 00

  And what we found is if you, if you track the acetylcholine release into the hippocampus, when the animals are actively eating, so they're holding food, they're chewing it, they're swallowing, the acetylcholine levels are ramping up when that's happening. And then when they stop, take a break, look around a little bit, starts to ramp down. And it kind of jigsaws like this throughout the meal. But one important finding is at the end of the meal, the baseline levels are higher than they were at the beginning. So it's, it's like a staircase in some ways. It's kind of like up, down, up, down. But then eventually it's, it's higher. We think that that elevated postprandial level of acetylcholine hippocampus is to allow the animals to remember what, what the hell's going on, you know, like just ate this meal.

• 1:19:25Speaker 00

  Where am I? Can I get back here and do this again?

• 1:19:28Andrew D. Huberman?

  That's definitely how I felt when I went to Portland some years ago and I had the best croissant I've ever had in my entire life, including in comparison to France.

• 1:19:37Speaker 00

  Yeah.

• 1:19:38Andrew D. Huberman?

  And I have a memory map of how to find that place, assuming it's still there.

• 1:19:42Speaker 00

  Probably is.

• 1:19:43Andrew D. Huberman?

  It's, it's.

• 1:19:43Speaker 00

  If it was that good, it's probably still.

• 1:19:44Andrew D. Huberman?

  It was that good. And I don't consume that many croissants, especially not these days. But like, yeah, there's really something to it. Like when you get awesome taste, awesome, hopefully nutrients also, it's like you collect your prior experiences leading to that. And I can see why that would be important for survival reasons, but I could also see why if this system was hijacked by highly processed foods, that why we're so in trouble nowadays?

• 1:20:13Speaker 00

  And we, we see the, the same, the animal reading healthy food versus like a high fat, high sugar diet. We see the same acetylcholine profile.

• 1:20:21Andrew D. Huberman?

  So this really does have an analog to like TikTok scrolling versus reading a, a chapter in a challenging book or interesting story.

• 1:20:30Speaker 00

  Yeah. What, what you said that made me think of something. You, you mentioned the taste and the nutrient. We don't see this with, with taste alone. So if the animals consume stevia, non nutritive sweetener, we don't see that the acetylcholine release patterns in the hippocampus. So it is, we haven't done it the other way around where we infuse the nutrients without taste. That's something that's in our queue to do in the near future. But I, my guess is what, is that you need the combination of, of taste and post-oral nutrient sensing to drive this, this vagal acetylcholine signaling to hippocampus.

• 1:21:05Andrew D. Huberman?

  How much is being done to really parse the, the character of the signal from the body to the brain? You know, the body, brain connection some years ago was considered really hippy dippy.

• 1:21:16Speaker 00

  Yeah.

• 1:21:16Andrew D. Huberman?

  And now everyone talks about it and the Vegas is the superhighway champion of this body, brain thing. We talk about in the context of breathing, meditation, trauma therapy, psychedelic therapies, learning, food, now food intake. And I get really excited when there's a repeating theme coming through on this podcast, when I sit down with experts like yourself. And I, I'm wondering, especially as a person coming from the visual system where we can describe like, okay, when a human sees a bar of light at this orientation of this intensity, we can trace the whole cascade now. That's a sensory system. This is a sensory system. Do we know what the nature of the signals are?

• 1:21:57Speaker 00

  But unlike the visual system, the interoceptive awareness is a very messy process. You know, it's, it's not a precise process. We, we can discriminate between I'm extremely hungry or I'm extremely full. But in between that, this is very much unlike the visual system. These sensory inputs coming in are, there's some neural, there's some endocrine. It's like a, a symphony of chaos in some ways. I don't think we're ever going to get to the precise level of, at least maybe I shouldn't say ever, but in the near future of really understanding the nature of that signal, the gestalt of that signal. One thing I, since I've been talking about the hippocampus a lot, it seems to be where

• 1:22:41Speaker 00

  this interoceptive awareness is being processed in the brain. So give you an example, if you take a human who's densely amnesic, who has damage to bilateral damage to the medial temporal lobe, including the hippocampus, and these individuals have episodic memory impairments. So their, their memory span is, you know, between 10, 30, 40 seconds, depending upon the individual. And you have them eating food, they'll consume a meal. Experimenter goes away, comes back with another meal, they'll eat the next meal. And this will happen even a third time. They don't remember eating the meal. But what's always fascinated me about

• 1:23:21Speaker 00

  this study and studies like this, I think Paul Rosin did the first one, is that if you ask them to rate their hunger and satiety level, like on a scale of zero to 10, they will be a seven out of 10 after eating three meals in a row. So of course they're getting this gut feedback to the brain. They're probably even feeling full, but they don't know how to interpret that signal. The hippocampus is needed to understand what that, that signal means. And there's analogous studies in rodents. Like if you do a lesion to the hippocampus, a normal animal can learn that a high level of energy restriction is different from not being food restricted. Like they can use that as a cue to predict something's about

• 1:24:05Speaker 00

  to happen, like a foot shock or a food pellet's coming. If you lesion the hippocampus, they, they can't do that. So it's interoceptive agnosia. They seem to be unaware of what this interoceptive signaling means. Even if they're detecting it at the sensory level, it doesn't, doesn't mean what it's supposed to mean. Doesn't allow them to appropriately guide their behavior based on that, that signal or sympathy of signals to do the appropriate action.

• 1:24:32Andrew D. Huberman?

  It seems that some people have so much interoceptive awareness and other people do not.

• 1:24:38Speaker 00

  Yeah.

• 1:24:39Andrew D. Huberman?

  And I, I wonder how that relates to food intake. You know, we've hosted world-class choreographers on here and athletes. And I always think of the people who move for a living as being really in tune with their body.

• 1:24:52Speaker 00

  Right.

• 1:24:52Andrew D. Huberman?

  And obviously they are, but then there's the rest of the population where we're not really trained to think about how our body feels in the context of daily living. We just kind of like live.

• 1:25:04Speaker 00

  When it comes to interoceptive awareness of hunger versus fullness, that can be impaired with, with a high fat, high sugar diet as well. So that's, that's a, a process that is plastic and susceptible to what we eat.

• 1:25:18Andrew D. Huberman?

  I'm editorializing here again, but I feel like so much of the challenge in being a, or the task rather, of being healthy these days, especially in the United States, is trying to figure out like what the fundamental healthy baseline was or is. And trying to get to that because clearly processed foods, but also just the nature of life. Like you even said earlier, like three meals a day for you. Some people, it's one meal a day. Like they all can work and that's great. That's also part of the challenge is people figuring out what works for them.

• 1:25:56Speaker 00

  Yeah.

• 1:25:56Andrew D. Huberman?

  And we don't really have like one system that our, our brain, body connection is optimized for, or built for. And I'm guessing that's because we went through periods of feast and famine as we evolved. We need this system to be dynamic.

• 1:26:11Speaker 00

  Yeah. Feast and famine and also physical activity as it relates to our, our daily lives. So you and I are physically active, but here we are sitting down.

• 1:26:21Andrew D. Huberman?

  Yeah. We sit and talk for a living.

• 1:26:22Speaker 00

  We sit and talk a lot.

• 1:26:22Andrew D. Huberman?

  Yeah.

• 1:26:23Speaker 00

  Stare at screens.

• 1:26:24Andrew D. Huberman?

  To me, I chuckle sometimes that a lot of what we're doing for health nowadays is about moving the outdoors inside. So it's like, people have their like red light and their gyms and their, you bring plants inside and we, you know, hydrate.

• 1:26:36Speaker 00

  Are these real by the way?

• 1:26:37Andrew D. Huberman?

  What's that?

• 1:26:37Speaker 00

  Are these real?

• 1:26:37Andrew D. Huberman?

  They are real. We have, we have someone combine. Yeah. They do a really good job taking care of them despite the black walls. They get their light. There's this idea that like, there's a proper way that we're trying to get back to. But I like to think about human evolution sort of from where we are now and kind of like it's the front edge leading forward. And it seems, again, that we're really focused nowadays as a culture, as a health culture, on trying to figure out like, what's the bad stuff that we didn't know was bad? And what's the bad stuff that hijacked us that we didn't realize hijacked us? Whether it's highly processed food, or whether it's a.

• 1:27:09Speaker 00

  Advanced glycation.

• 1:27:10Andrew D. Huberman?

  Short form content or like, and we, we have always like process of error correction. Like we sort of stumble forward.

• 1:27:17Speaker 00

  Yeah.

• 1:27:17Andrew D. Huberman?

  And then we kind of get pulled back. Error correction, keep going. I mean, these are the issues that people really wonder about. Like what should I eat to keep my memory? I guess the question, what shouldn't I eat? What shouldn't I do is far easier to answer. But the omega three fatty acids seem to have a pretty decent literature.

• 1:27:36Speaker 00

  Yeah.

• 1:27:36Andrew D. Huberman?

  There's a woman, forgive me, I'm forgetting the name. We'll put it in the show note caption who has a laboratory up at UC Santa Barbara, who's looked at supplementation with omega threes during pregnancy and brain size and function in a human offspring. It seems like the omega threes, the polyphenols, enough protein. It seems like those are critical.

• 1:27:57Speaker 00

  Yeah. There's a few players that are established. You've, you've hit on, on the main ones. Yeah.

• 1:28:01Andrew D. Huberman?

  What is your read of the omega three literature in terms of, like, if you, have you done experiments where you give animals enhanced levels of omega three?

• 1:28:09Speaker 00

  We have not done that. No, the, in my lab, we're focused more on what's, what's bad, you know, what's, what's not optimal for brain development. And the only interventions that we've done is either replace a bacteria population in the gut, or to just simply switch to a healthy diet. So we, we, I'm aware of, of those studies, but we haven't modeled that in, in our lab.

• 1:28:34Andrew D. Huberman?

  Tell me about the microbiome studies.

• 1:28:36Speaker 00

  Sure. So we, we.

• 1:28:39Speaker 00

  Basically, I'm not a microbiologist, so I just want to leave with that. My background is psychology, so I got into the microbiome largely by accident and curiosity about 10 years ago. And we found that in this early life excessive sugar model that we were using in rats years ago, the microbiome was completely different. So if you do like a principal court analysis and you kind of see that the overall pattern of the bacterial population, the animals getting the sugar were just extremely different. And that could be for a lot of things. It could be from the sugar, or it could be these animals are consuming a lot of their calories from the sugar, so they're getting less fiber and less nutrients that are in the chow.

• 1:29:22Speaker 00

  That aside, there's definitely a change that's happening. And we looked at individual populations. Can we correlate the abundance of this population with the animal's memory performance in one of these memory tests that I described earlier? And in one case, we had a population parabacteroides that was elevated in the sugar group, I think maybe twofold enough that it was significant and noticeable, and it was negatively correlated with memory performance. So then we, in a separate study, we did an antibiotic treatment to kind of wipe out the bacterial population a little bit, not completely eliminate. And then in that state, we enriched this population into the gut, and the animals showed

• 1:30:07Speaker 00

  memory impairments, even though they had never consumed sugar. So we were able to kind of replicate, and in many cases, the memory impairments are more severe when we enriched this population, but it was enriched maybe eightfold and more than what you were getting from the sugar. So that's an example where we found a population that seemed to be negatively impacting the performance. In the pre-print paper that I mentioned earlier, where we have this heat-treated age-enriched diet model, we found another population, and this one's Lactococcus, it's a lactic acid-producing bacteria that was completely eliminated when we heat-treated the diet. And in this case, its performance was positively correlated with memory performance, and we

• 1:30:51Speaker 00

  were able to rescue the memory impairments by enriching that population. So these are the kinds of things that we can do with microbiome studies. There's, of course, fecal transplant. We haven't done much of this, but a lot of people have in the field where you just transplant the fecal and sequeal content from one group of animals to another, and in that case, you can kind of replicate some of the behaviors simply by doing that. But in that case, you're changing everything. It's not just a single bacterial population. So we've looked more at, can we identify a bacteria that seems to be changed by the diet and correlated with what we're looking at? And then can we replicate or reverse something by putting it in?

• 1:31:33Andrew D. Huberman?

  Very cool. I'm excited to read the pre-print and see the paper come to publication, full fruition. Because for a long time, when I talked to my colleagues about microbiome, who work on the microbiome, like, okay, which bacteria are beneficial? And they go, diversity. I go, I get it. Which ones are most beneficial? And I realize, in this case, you did a rescue, so you had a diet, just to summarize, in case people will miss any, like, although you described it beautifully, a diet that leads to some memory impairments, this is the diet associated with these Maillard high heat reactions. You can rescue some or all of the deficit by replacing a single bacteria. That doesn't mean that increasing that bacteria to superphysiological levels will increase

• 1:32:16Andrew D. Huberman?

  memory linearly, but this is offsetting damage, what we call rescue, or it used to be called gain of function, but now people ran with that term in different directions. It's not a popular term. And I've been just kind of obsessed with like, okay, I get it, like gut microbiome diversity, but which bacteria are the ones that we want? And it's very, very difficult for anyone, experts in that field, to give me a clean answer. And I think it's because they just don't know.

• 1:32:42Speaker 00

  Yeah, I think that's it. I don't think there is a clean answer, and part of the reason for that is, in 2012, that's when the, approximately when the Human Microbiome Project ended, and before that point, we didn't really have an idea about the genetic makeup of the bacterial population in the human gut. So if you go pre-2012, this was not really a field of research. In fact, if you did a PubMed hit, so PubMed is the database for biomedical publications, 10 years ago, you might have pulled up 7,000 hits. Today, 250,000? It's just such a new field of biomedical research that we don't have these answers.

• 1:33:23Speaker 00

  And yeah, you can find some bacterial populations that, as I just described, a few, that seem to be bad in one context or good in a different context, but then it can be completely flipped in a different study with a different treatment. And the abundance of one population is going to affect the abundance of, you know, hundreds, if not thousands, of other populations. It's just such a complicated thing, and it's such a new field of research that I don't think you can say with clarity, like, here are the good bacteria and here are the bad bacteria. We're not even close to that.

• 1:34:00Andrew D. Huberman?

  Yeah, the throwaway answer right now is diversity. It reminds me of the 90s, I'm old enough to remember, it was like, exercise. And I was like, well, what kind of exercise? And people said, well, weight training isn't good because muscles will turn to fat after you stop. So cardiovascular exercise, you say, what form? And now it's very nuanced. It's like some combination of high-intensity interval training, longer, slower training, resist, like, now we have answers because there's been 20-plus years or 30-plus years of really good studies and people attacking it seriously. I've got a family member who, right now, is taking a very high-dose spectrum of antibiotics because they unfortunately had a sepsis-type situation.

• 1:34:42Andrew D. Huberman?

  And they are very sharp in the mind ordinarily, and they were saying they're really struggling to think, like, really struggling to think. And so they're trying to repopulate their gut bacteria with, you know, I'm a big proponent, based on Sonnenberg's work of low-sugar fermented foods, so sauerkraut, kimchi, kefir, you know, all these incredible foods that we know really support the gut microbiome. And so they're doing that and feeling better, but of course, they're destroying their gut microbiome intentionally every day at the same time. And I said, if you can just get through this period, defeat the infection, you're going to experience such a robust return, but it's a slow system. Like, this isn't the kind of thing where you take a pill and you feel better. The gut microbacteria take, as my understanding is, it can take weeks or months to really

• 1:35:25Andrew D. Huberman?

  build up a quote-unquote "healthy gut microbiome." It's not something you just do overnight or with one meal.

• 1:35:30Speaker 00

  No, it's not, and it's very plastic, dynamic system. Like, with some exceptions, there's, have you heard of C. diff?

• 1:35:38Andrew D. Huberman?

  No.

• 1:35:38Speaker 00

  So this is like an intestinal issue where generally from people in hospital were taking antibiotics, antibiotics deplete bacteria, and they'll deplete good and bad bacteria. And with C. diff, there's bacteria that normally keep this C. diff in check. And with C. diff, there's a lot of this bacteria which leads to sort of violent GI distress and can even lead to death. And there's an FDA-approved fecal transplant procedure for this specific syndrome. So, and I believe it's typically with a single transplant.

• 1:36:16Andrew D. Huberman?

  Amazing.

• 1:36:17Speaker 00

  Is enough to correct this in a high percentage of individuals. So there's a bright future for this. I don't think we're there yet. I mean, to my knowledge, that's the only FDA-approved. There could be others, but that's the only one I'm aware of, fecal transplant or targeted bacterial treatment. But I think it's just such a new field of research. We're definitely in the baby stages of understanding this complex relationship.

• 1:36:43Andrew D. Huberman?

  I was a little bit dismayed when I heard early on that your ideal gut microbiome is really, the upper threshold of that is established in the first three years of life. And I thought, there's no way my parents got this exactly right. But then we learned that it's a little bit like the way learning and neuroplasticity was discussed. It used to be considered that, okay, up until your teens, early 20s, that was the opportunity for wiring the brain a particular way, and then it's locked in. And we know that that's not true at all. And so there's great plasticity, if you will, to the system, which I find immensely reassuring.

• 1:37:16Speaker 00

  And diet is a huge, and probiotics, these are, this is how you change that plasticity.

• 1:37:22Andrew D. Huberman?

  I'd like to take a quick break and acknowledge our sponsor, Function. Function provides over 160 advanced lab tests to give you a clear snapshot of your bodily health. This snapshot gives you insights into your heart health, your hormone health, autoimmune function, nutrient levels, and much more. They've also recently added access to advanced MRI and CT scans. Function not only provides testing of over 160 biomarkers key to your physical and mental health, it also analyzes these results and provides recommendations for improving your health from top doctors. For example, in a recent test with Function, I learned that some of my blood lipids were slightly out of range. As a result, I decided to start supplementing with nattokinase, which can naturally help reduce LDL cholesterol.

• 1:38:07Andrew D. Huberman?

  And it did. In a follow-up test, I could confirm that this strategy worked. My blood lipids are now back exactly where I want them. Comprehensive lab testing of the sort that Function offers is just so important for health. I mean, how else are you going to know what's going on under the hood? And while I've been doing blood work for years, it used to be time-consuming, complicated, and expensive. In fact, I used to spend thousands of dollars per year trying to get this kind of data, and the data, frankly, were not all that good. But now with Function, it's extremely easy and affordable. A Function membership is only a dollar a day, $365 a year. And if you think about the information it provides, and the health challenges it helps you avoid, and the proactive things that it can do for you to enhance your health, I truly look at it as a savings.

• 1:38:50Andrew D. Huberman?

  To learn more, visit functionhealth.com/huberman and use the code HUBERMAN for a $50 credit towards your membership. Again, that's functionhealth.com/huberman. Yeah, I now think about the gut so differently than I did even a couple of years ago, based on conversations like this. Like, there's the vagal pathways, which, we don't know the time scales they work on, but they can be relatively fast. And then there's the gut microbiome. I think about the gut, like gut health and its relationship to general health, including brain health, as I need to give my gut microbacteria the things they need so that they can create the things that my brain and body need.

• 1:39:31Andrew D. Huberman?

  So it's just like raw materials, short-chain fatty acids leading to neurotransmitter neuromodulator production like serotonin. I just need to give them what they need. And no, this isn't a, you know, a product endorsement, because my observation is that... It comes mainly from these low sugar fermented foods, getting enough fiber and not stressing too much because stress can also impair the gut microbiome and getting enough sleep. And so maybe at the end of the day, it really is all about supporting the gut microbiome. I guess in there are other things too. It seems that important. And I think it's only really sinking in for me just how important it is. And as a child of the, born in 75, like the 90s were just terrible for this. It was like low fat. I guess there was some emphasis on fiber.

• 1:40:16Speaker 00

  I lived through that period as well.

• 1:40:17Andrew D. Huberman?

  Yeah, it was, it was the advent of margarines and processed foods really came in.

• 1:40:21Speaker 00

  Olestra.

• 1:40:22Andrew D. Huberman?

  Fortunately, I never, never had an Olestra chip. I wasn't interested in the, the leakage. Yeah, that's it. That was enough of a barrier.

• 1:40:33Andrew D. Huberman?

  We'll move to reinforcement in a moment, but you reminded me of the 90s when the, the fen-phen drugs were released, phenfluramine. These were supposed to be blockbuster drugs, kind of like the GLPs, but they were basically stimulants, right? And then people started having heart attacks. Is that what?

• 1:40:50Speaker 00

  Simpaticinometics. Yeah, there's some cardiovascular outcomes that were unwanted and led to the discontinuation of that. And then the, the obesity drug market was dormant for many, many years until around 2010 and beyond when we, it wasn't just GLP-1 drugs. It was a few other ones that have kind of fallen out of favor because the GLP-1 drugs are the most effective. But yeah, there was a period of time and probably largely due to the fen-phen issue where pharmaceutical companies were not interested in developing obesity drugs. But at this point, 40, over 40% of US adults are obese. It's hard to.

• 1:41:29Andrew D. Huberman?

  Over 40%?

• 1:41:29Speaker 00

  Over 40%.

• 1:41:30Andrew D. Huberman?

  That's unbelievable.

• 1:41:32Speaker 00

  So it's, it's, it's not something that can be ignored now in the 90s. Wasn't 40%?

• 1:41:37Andrew D. Huberman?

  Yeah.

• 1:41:37Speaker 00

  Might've been 20 then?

• 1:41:38Andrew D. Huberman?

  Yeah. I mean, it's hard for people to remember and I'm not being disparaging of anyone, but just by recollection, like in junior high school or high school, there were probably a few kids in my class that were, you know, visibly quite overweight, maybe a couple that were a bit overweight, but it was rare. You just didn't see it.

• 1:41:59Speaker 00

  Yeah.

• 1:42:00Andrew D. Huberman?

  And then there would be these television shows about people who were, they used to call it, it's not a kind term, but they would call it morbidly obese, you know, and they removed them from a building with a crane or something. It'll be like Geraldo would do an episode and so you were aware that it happened, but it was really like these extremes of pathology. You just didn't really see very, very, lots of very, very overweight people.

• 1:42:20Speaker 00

  And back then, type 2 diabetes was called adult onset diabetes. And for reasons you're getting at, it's now not called that because we, we get, you know, not high percentage, but a noticeable percentage of, of children and certainly teenagers who develop type 2 diabetes.

• 1:42:38Andrew D. Huberman?

  Do you think it was all the highly processed food industry?

• 1:42:41Speaker 00

  I, I don't want to say anything was all, but it certainly contributed. Yeah. And I didn't, I grew up with an ad lib access to Mountain Dew and yeah, it was just a different time.

• 1:42:54Andrew D. Huberman?

  Yeah, school lunches used to be like a sandwich with maybe a bag of chips or a cookie.

• 1:43:00Speaker 00

  Cookie, yeah.

• 1:43:01Andrew D. Huberman?

  Like it was one or the other. You had to pick, you know, and soda wasn't really, you could get soda, but it was more like a treat.

• 1:43:09Speaker 00

  My high school, we had an à la carte lunch. So you could buy like a pretzel with nacho cheese dip. You could buy whatever you wanted. It wasn't, there was no standardized, here's a healthy meal.

• 1:43:20Andrew D. Huberman?

  So lunch has changed so fast, but it looks like the error correction is coming in and hopefully not only in the form of GLPs. I mean, one of the reasons I do this podcast is to try and take, you know, showcase serious scientists and clinicians who are like extolling the virtues of eating well, healthily for people of all ages. But all right, I've alluded to it so many times now, it's almost seems like, like I'm teasing, but here we are, reward reinforcement, enticement. Most people are familiar with the word dopamine. They think of it as pleasure. Most people, thanks to Onalemki's book, Dopamine Nation, now end the book, The Molecule of More, which is also excellent, in my opinion, that dopamine is about craving, wanting motivation,

• 1:44:03Andrew D. Huberman?

  at least as much and probably more than it is about pleasure.

• 1:44:08Speaker 00

  That's true. Yeah.

• 1:44:09Andrew D. Huberman?

  So in the context of food and food intake and nutrient intake and memory, what is the role of the reinforcement pathway? What you and I call the mesolimbic reward pathway?

• 1:44:22Speaker 00

  This system, which the most basic description of it would be a mid, midbrain ventral, tegmental area to the nucleus accumbens. That's kind of the, the classic mesostriatal dopamine projection. And this system is engaged by palatable foods. So like liquid sucrose, a high fat sucrose combination, but there's a little bit more to it than that. So you can get the system engaged by a bland tasting, healthy food when an animal's food restricted, or you can get the, the system engaged by, by water when an animal's water

• 1:45:01Speaker 00

  restricted, or even a sodium deplete animal will show a dopamine release in this pathway to, to sodium consumption. So it's, it's, it's very much dependent upon the, the animal state. That said, palatable foods tend to tickle that pathway more so than what we consider to be more healthy and bland foods. And then of course, substances of abuse tap into the same system, albeit to a different degree, but it's definitely a common brain currency for, for things that we enjoy.

• 1:45:38Andrew D. Huberman?

  So when I hear you say that if we are food restricted or we just haven't, we're very hungry, doesn't have to be fasting, that bland foods can activate the dopamine reward pathway, a reinforcement pathway, excuse me, I'm trying to be more careful with my language. I wonder whether eating highly palatable foods or, or even just sweet foods changes our threshold for what we consider reinforcing and, and, and rewarding. I try to eat healthy and I noticed that I really love and crave blueberries and I keep mentioning them, but, and other foods. But if I eat healthy foods and I like the way they taste, I find that I crave those

• 1:46:20Andrew D. Huberman?

  foods and I don't tend to crave other foods, presumably because I'm sated, I'm not, I'm not excessively hungry. But is there a way that we can recalibrate this system? It seems there is.

• 1:46:31Speaker 00

  I think so. I mean, the examples you're saying make, make a lot of sense and individuals who consume a lot of sugar, who stop consuming it or consume much less, they, they change their preference, you know, something that they normally would have enjoyed is now too sweet. So there's a lot of plasticity in terms of what we want to eat and that's based largely on what, what we choose to eat. We can, we can, we can change that as you've described. Like you probably weren't craving blueberries when you were 12, maybe.

• 1:47:02Andrew D. Huberman?

  I mean, I've always liked fruit, but I liked other stuff too. And I, it's not like I actively avoid ice creams and things like that, but I, but I feel like it's different with food than it is with other reinforcing substances because if somebody who really craves alcohol, who really craves stimulants is deprived of those and then gets a small amount of it, I don't know that they say, oh, that just, I didn't like that experience. Usually it's like, they really like that experience. But here it seems we can rewire the, the circuitry toward healthier choices and maybe even to the point where what used to be rewarding is now aversive. And that is how I feel about, like the other day I had a sip of a milkshake, expecting it to be like delicious.

• 1:47:44Andrew D. Huberman?

  And I was like, oh, like I felt like it was like, it was so unbelievably sweet. I felt like I needed a palate cleanser afterwards. And, but there was a time when I really enjoyed a vanilla milkshake and I bet if I kept drinking that vanilla milkshake, I would start to enjoy it again.

• 1:48:01Speaker 00

  Yeah.

• 1:48:01Andrew D. Huberman?

  So I'm not sure people understand the plasticity of the system. So is it about the amount of dopamine is that, is the threat, like the upper threshold set by the most potent things like speed, milkshakes, you know, and banana split? And then if you don't eat those, so you don't consume those or take those substances, then, then you can get to that same high threshold with healthy choices? Or is it that, that the lower threshold just starts at the upper threshold?

• 1:48:31Speaker 00

  I don't know. I don't think those, those careful studies haven't, haven't really been done. I mean, there's ways to, to measure with PET dopamine, a proxy of dopamine binding in the human brain. In animals, we have really nice tools. I mentioned the acetylcholine sensors with fiber photometry. We also use dopamine sensors in my lab. So we, we can record dopamine release, again, when the animals are awake and doing things. We haven't looked at, the question you're getting at is how plastic is that system? The most extreme example of the plasticity of that system is with like a conditioned taste aversion, right? So if you have an animal who normally they consume sucrose, they will get dopamine release

• 1:49:15Speaker 00

  in that pathway, either when exposed to a cue that predicts that sucrose is forthcoming or the actual consumption of the sucrose. But then if you subsequently treat the, or train the animal, that, that sucrose consumption is associated with malaise. They'll inject like a, a compound that makes the animals uncomfortable for a few minutes. They attribute that feeling to consuming the sucrose. With that kind of training, you will eliminate that dopamine response that you see to sucrose. So that's just the most extreme example, the plasticity of this system.

• 1:49:50Andrew D. Huberman?

  Humans have tried to use the aversion approach to learning, basically giving people things that make them feel sick or electrically shocking them to try and rewire everything from, and these are not ethical studies, but people in the, in the old days, like the 60s and 70s, they tried to use this to like conversion therapy, right? For, for sexual orientation, obviously terrible. And fortunately that's illegal now, but the, but I'm not aware of any like really good studies showing that people will quit smoking if they're like electrically shocked when they pick up a cigarette. My, my understanding of these studies, maybe this is not true, but I, I was told by somebody

• 1:50:31Andrew D. Huberman?

  who worked in this general area that people basically just figure out how to endure the shock, like that's how rewarding nicotine is. And I, I wonder if there's something going on with the processed food aspect too, because...

• 1:50:47Andrew D. Huberman?

  I don't know that people really enjoy those foods. I feel like there is, when we hear that they're addictive, I don't know that that's the proper word, but they are impairing people's health. But there seems to be this thing where people get into this kind of like, it's not pleasure, it's not hedonia, but it's this kind of like mind, I don't want to say mindless, but there's, there's some no man's land of eating and consuming, not getting the thing they're looking for. That looks a lot like addiction.

• 1:51:15Speaker 00

  Yeah.

• 1:51:16Andrew D. Huberman?

  That looks like chronic drug use, but it's not like they're getting high off the food.

• 1:51:21Speaker 00

  Yeah, I mean, it's tricky making the comparisons because yeah, there's a common currency in the brain for substance abuse and palatable foods, but you have to eat every day, you know? Like this isn't, it's not a choice, like, and there's a lot of controversy in whether there can be an addiction to food. And I know we're going to take a side on either, either side of that one, but if you look at the DSM, criteria for substance abuse or addiction, you can make an argument that there is food addiction based on those criteria, but that doesn't mean that it's the same thing.

• 1:51:58Andrew D. Huberman?

  Yeah, continue to use, continue to harm to self for others. Yeah, inability, stop desire, these kinds of things. Late last year, there was a really interesting set of videos that were authenticated. The discussion was should food stamps be allowed to be used to purchase soda? And someone from the American Heart Association was asked on this panel, what do you think? Do you think soda is healthy? And they, and they did this incredible, but really dismaying, in my, in my opinion, tap dance around, well, you know, in the context of this and this and that. I mean, they did everything they could to avoid answering the question, basically.

• 1:52:40Speaker 00

  Sugar lobby is very powerful.

• 1:52:41Andrew D. Huberman?

  Yeah.

• 1:52:41Speaker 00

  Or has been historically.

• 1:52:43Andrew D. Huberman?

  Are these health associations like the American Heart Association, are they really like in bed with the sugar lobby? To me, that seems a little bit like a, like a movie that I'm hoping isn't real, but in the end, they, I think they took soda off the, the list of things that could be purchased with these stamps.

• 1:53:01Speaker 00

  Well, that's good.

• 1:53:01Andrew D. Huberman?

  I believe that's the outcome because there was enough social pressure because of social media and this just went wild. But is it really the case that our medical industry is in bed with the processed food industry? I mean, hospitals have some of the worst food in the world, not Stanford Hospital, but I'm sure not USC Hospital.

• 1:53:17Speaker 00

  Definitely not USC.

• 1:53:18Andrew D. Huberman?

  Yeah.

• 1:53:18Speaker 00

  Definitely not.

• 1:53:19Andrew D. Huberman?

  But many hospitals you go in and the goal is to get people many calories for very little money. And that's understandable, why they feel they need to do that. But you just go, my God, the nutrition here is just dreadful and this is a hospital. So my mind goes to like, it might be true, but is it true? Do we know?

• 1:53:37Speaker 00

  It certainly seems possible. I mean, I've, as someone who's researched the negative impacts of sugar consumption, I've, I've had a few brushes myself with, with the sugar lobby.

• 1:53:50Andrew D. Huberman?

  Oh, really?

• 1:53:50Speaker 00

  In my career.

• 1:53:51Andrew D. Huberman?

  Have they, you've had someone detailing your car?

• 1:53:54Speaker 00

  Not quite to that level.

• 1:53:55Andrew D. Huberman?

  Okay.

• 1:53:56Speaker 00

  More of a public facing statements, but, but yeah, to the extent that that's influencing our policy, I don't know.

• 1:54:06Andrew D. Huberman?

  So you've had the sugar industry giving you shit, basically?

• 1:54:10Speaker 00

  Yeah, early, early in my career, we had a, it wasn't even published yet. It was from our early life sugar model that I talked about earlier, where there was a press release. It wasn't through me trying to get it noticed, it just got picked up for something. And when you get pressed, that's when the sugar lobby, for lack of a better term, may have a forward public statement about that particular study.

• 1:54:34Andrew D. Huberman?

  To try and protect themselves.

• 1:54:35Speaker 00

  Yeah, exactly. And generally it's not a, that's a great study kind of comment, but that was a long time ago.

• 1:54:43Andrew D. Huberman?

  Yeah, don't worry, you're safe. Actually, by saying this here, you're actually safer now. Also, the world's changed and nobody, nobody trusts big institutions anymore, especially medical related institutions, which in many ways is both good and bad.

• 1:54:56Speaker 00

  Right.

• 1:54:56Andrew D. Huberman?

  Because, you know, if you're right.

• 1:54:58Speaker 00

  Definitely.

• 1:54:59Andrew D. Huberman?

  God forbid someone has to have surgery, you want an excellent surgeon, like you can't just like, you can't just like health and wellness that, you know? But, but the, and on and on, but it's, I do think we've experienced a tide change. Now, I think the United States is really on board that things need to change. In fact, this week we have an episode out with Michael Pollan, who's written extensively about the food industry and plants and, and health. And he actually was very, it was really remarkable. I'll provide a link to this, that one segment in the caption for anyone that wants to see it. He, he really said, he's like, in order to move the health of this country forward, there, it needs to be a bipartisan effort. Like the fact that there's an emphasis on improving nutrition, but it really just focused

• 1:55:43Andrew D. Huberman?

  on food dyes and he wasn't so thrilled about that. But then he actually tipped his hat to some of the things that the administration has been doing, but then also pointed out some of the things that they were doing, like related to liberating the use of pesticides that was not good. So he has a very balanced view of this and I, and he make, and is able to say, we need to get away from the politics if we ever want to move forward and be a, an actually healthy country.

• 1:56:06Speaker 00

  I think we still have a long ways to go.

• 1:56:08Andrew D. Huberman?

  We do, but there's hope.

• 1:56:10Speaker 00

  There's hope.

• 1:56:11Andrew D. Huberman?

  And you and I are young enough and our gut microbiomes hopefully are healthy enough that we will remember what we need to know moving forward.

• 1:56:18Speaker 00

  Exactly.

• 1:56:19Andrew D. Huberman?

  And there's this whole other generation of young kids that grew up, I'm, I'm realizing like, thinking about food, nutrition, exercise, sure, through the fire hose of social media where there's a lot of like bad information too, but they, many, many of them think about taking really good care of themselves. And if they grew up in a home where that wasn't a priority, they think about it and they're helping people. And I like to think that things are changing. Before we wrap, I do have a question about oxytocin.

• 1:56:48Speaker 00

  Yeah.

• 1:56:48Andrew D. Huberman?

  Most of us think of oxytocin as a little love.

• 1:56:52Speaker 00

  Lovey dovey.

• 1:56:52Andrew D. Huberman?

  Lovey dovey hormone neuromodulator. Educate us on the role of oxytocin in the context of food intake and nutrition.

• 1:57:02Speaker 00

  It's been known for quite some time that, that oxytocin can reduce appetite and food intake. And through careful studies from Harvey Grill and others, we have identified the brainstem as being the, the most robust target of oxytocin signaling to reduce food intake. So oxytocin is released or created in the PVH in the hypothalamus, released into the circulation, but also there's projections from oxytocin producing neurons throughout the brain. And some of those neurons project to, directly to the brainstem. And that system seems to be an important system for reducing food intake, mainly through

• 1:57:42Speaker 00

  the level of meal size, making meal size smaller, increasing satiation. We had a study recently where we were looking at its role in the hippocampus. And in this case, we found some results that were a little bit surprising, I should say. There's a phenomenon in, in humans that rodents also show, it's called the social facilitation of eating. So if you and I are, if you're eating alone, you might eat less than if you're eating with a group of people. And if those people are familiar to you, you're going to eat more than if they were unfamiliar. So that's kind of the, the, the gist of the phenomenon. And we can model this in rodents.

• 1:58:23Speaker 00

  And we found that that phenomenon requires oxytocin signaling in the hippocampus. So if you genetically turn down the signal, the animals don't show that effect. So this is kind of a different role for oxytocin because under these conditions in this brain region, it's actually promoting intake in a social context. So I think it's, it's really complicated, like most things in the brain are. But historically, the, it's been a unit, unit direction, that oxytocin in the brain reduces food intake. But some of recent findings from our lab and others are saying, well, maybe yeah, but it might depend on the, the social context, for example, and where the signal's getting to.

• 1:59:04Andrew D. Huberman?

  Well, Scott, thank you so much for coming and sharing your mechanistic data. I love that you're highly mechanistic. Offline, I want to know the, the literal organization of these cholinergic affections to the hippocampus, because I think that's more of an aficionado question. But it's clear that you're studying a really, really important system for the health of all humans and especially right now with the highly processed food thing, but also the GLPs and also the, this explosion of discoveries in the microbiome and the positive explosion of people that are interested in doing what they can for their brain and bodily health. You're, you're clearly in the right area, evidenced by the fact that I said, if you had a vault, what of money, what would you study? And you're like, what I'm doing right now.

• 1:59:49Andrew D. Huberman?

  So you're clearly in, in the right laboratory which you run. So thank you, thank you for doing the work that you do. And it's not lost on me and it shouldn't be lost on the audience that you do that work with taxpayer dollars. So you're working on our behalf for our health. So, and you're very busy. So thanks for coming here today. Appreciate you.

• 2:00:06Speaker 00

  Thank you very much. Appreciate it. It's been fun.

• 2:00:08Andrew D. Huberman?

  Great. Next time, bring your dog.

• 2:00:09Speaker 00

  I will.

• 2:00:10Andrew D. Huberman?

  Awesome. Thank you for joining me for today's discussion with Dr. Scott Kanoski. To learn more about his work, please see the links in the show note caption. If you're learning from and/or enjoying this podcast, please subscribe to our YouTube channel. That's a terrific zero cost way to support us. In addition, please follow the podcast by clicking the follow button on both Spotify and Apple. And on both Spotify and Apple, you can leave us up to a five star review. And you can now leave us comments at both Spotify and Apple. Please also check out the sponsors mentioned at the beginning and throughout today's episode. That's the best way to support this podcast. If you have questions for me or comments about the podcast, or guests or topics that you'd like me to consider for the Huberman Lab podcast, please put those in the comments section on YouTube. I do read all the comments.

• 2:00:53Andrew D. Huberman?

  And if you're not already following me on social media, I am Huberman Lab on all social media platforms. So that's Instagram, X, Threads, Facebook and LinkedIn. And on all those platforms, I discuss science and science related tools, some of which overlaps with the content of the Huberman Lab podcast, but much of which is distinct from the information on the Huberman Lab podcast. Again, it's Huberman Lab on all social media platforms. And if you haven't already subscribed to our neural network newsletter, the neural network newsletter is a zero cost monthly newsletter that includes podcast summaries as well as what we call protocols in the form of one to three page PDFs that cover everything from how to optimize your sleep, how to optimize dopamine, deliberate cold exposure. We have a foundational fitness protocol that covers cardiovascular training and resistance training.

• 2:01:37Andrew D. Huberman?

  All of that is available completely zero cost. You simply go to hubermanlab.com, go to the menu tab in the top right corner, scroll down to newsletter and enter your email. And I should emphasize that we do not share your email with anybody. Thank you once again for joining me for today's discussion with Dr. Scott Kanoski. And last, but certainly not least, thank you for your interest in science.